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Cyanide and nitrosoamines (NAs) are ubiquitous compounds, found in our food 
and water, either by natural process or through man-made activities. The toxicity of 
cyanide is exerted by its ability to inhibit metalloenzymes such as cytochrome c oxidase, 
causing concomitant cascades of biochemical effects such as lactic acidosis, inhibition of 
ATP production, respiratory seizure, and potential death. Nitrosoamines, on the other 
hand, undergo biotransformation (metabolic activation in cytochrome P450) in the body 
to produce unstable intermediates that alkylate DNA, causing mutations, and leading to 
carcinogenesis.  In order to further the advancement of a promising cyanide, cobinamide 
(Cbi), an LC-MS-MS method was developed to analyze cyanide-complex Cbi, while an 
ICECLES-GC-EI-MS procedure was developed to detect nitrosodipropylamine (NDPA) 
at low concentrations in drinking water via a flexible, facile, relative easy performed, and 
green method. 
Cbi has shown promise as a therapeutic for cyanide poisoning. While current 
analysis techniques only measure total Cbi, methods to elucidate the behavior of cyanide-
bound Cbi, total Cbi, and available Cbi (i.e., the difference between cyanoCbi and total 
xvii 
 
 
 
Cbi) would be valuable for biomedical and pharmacokinetic studies. Therefore, a method 
was developed for the analysis of cyanoCbi in plasma via liquid chromatography-tandem 
mass spectrometry (LC-MS-MS). Plasma samples were prepared by denaturing proteins 
with 10% ammonium hydroxide in acetonitrile. The resulting mixture was centrifuged, 
and the supernatant was removed, dried, and reconstituted. CyanoCbi was then analyzed 
via LC-MS-MS. The limit of detection was 0.2 µM, and the linear range was between 1-
200 µM. The accuracy was 100±17% and the precision, measured by relative standard 
deviation (%RSD), was ≤18.5%. Carryover, a severe problem when analyzing Cbi via 
liquid chromatography, was eliminated using a polymeric-based stationary phase (PLRP-
S) and a controlled washing protocol. The method allowed evaluation of the cyanide-
bound and ‘available’ Cbi from treated animals and, when paired with a method for total 
Cbi analysis. This method allowed for estimation of Cbi utilization when treating cyanide 
poisoning and verified for the first time, the hypothesized mechanism of treatment of 
cyanide poisoning by Cbi (direct binding of cyanide). 
To overcome the challenges associated with the analysis of NAs at ultratrace 
levels (i.e., difficult extraction protocols, laborious sample preparation techniques, and 
requirement for sophisticated/expensive instrumentation), an advanced sample 
preparation technique, ICE Concentration Linked with Extractive Stirrer (ICECLES), 
coupled to an inexpensive low-resolution gas-chromatography electron ionization mass-
spectrometry instrument was used to analyze NDPA (MRL = 7 ng/L (ppt)). An LOD of 
0.2 ng/L was obtained for NDPA, along with linear range of 2 to 50 ng/L was produced 
(using NDPA-d14 internal standard). Both inter- and intraassay precision were ≤13%RSD, 
while the method accuracy was 100±17.5%. The ICECLES method was applied to screen 
xviii 
 
 
 
for possible NA contamination in selected drinking water sources. The concentration of 
NDPA in one drinking water source was 2.38±0.34 ng/L. Moreover, NDPA was detected 
in the two other municipalities tested (i.e., concentrations > 0.2 ng/L), but it was not 
quantifiable.
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CHAPTER 1. INTRODUCTION 
1.1.Overall Significance and objectives 
Cyanide is a toxic chemical that may be introduced into living organisms by 
natural process and/or anthropogenic uses [1]. Potential sources of cyanide include 
edible and non-edible plants (such as apricots, stone seeds, and cassava), cigarette 
smoke, and occupational exposure from industrial operations such as plastic 
processing and paint manufacturing. Over one million tons of cyanide are used for 
industrial purposes, such as being the lixiviant of choice in the mining industry [2]. 
Cyanide has been used as a chemical warfare agent for terrorist purposes, and for 
criminal purposes. Cyanide causes toxicity in living organisms by inhibiting 
cytochrome c oxidase in the mitochondria, resulting in impairment of oxidative 
phosphorylation, and subsequently leading to progressive lactic acidosis, histotoxic 
hypoxia, cytotoxic anoxia, and ultimately, death [3-5]. Cobinamide (Cbi) is a novel 
cyanide antidote proposed to be superior to available FDA-approved therapeutics. 
However, current methods for analyzing Cbi in biological systems lack the ability to 
measure the available Cbi, which is imperative to understand the pharmacokinetic 
behavior in order to approve Cbi as a cyanide antidote. Therefore, the objective of our 
work was to create a method for the analysis of Cyano Cbi. This method would pair 
with a method to detect the total Cbi previously developed in our lab to allow 
quantification of the available Cbi [6]. 
Nitrosoamines (NAs) are potent mutagens, carcinogens, and teratogens. NAs 
exert their toxicity by a series of metabolic activation in cytochrome P450 through 
hydroxylation of the α-C-atom of the N-N=O group of NAs. The α-hydroxy 
nitrosamine is highly unstable, and can easily degrade to form formaldehyde and 
methyldiazohydroxyde. The fate of these compounds leads to the production of 
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diazonium ion or a carbenium intermediate, which both have the propensity to 
alkylate DNA, RNA and proteins, leading to mutations, and ultimately carcinogenesis 
[7-11]. NAs are associated with food and soils, and are typically, together with their 
precursors, found in agro-chemicals, tanned leather products, solvents, cutting fluids, 
drugs, plastics, rubber additives, detergents, and ground or drinking water. Drinking 
water is perhaps one of the most concerning routes for NA exposure [12].  NAs are 
formed during the water purification process as a disinfection byproduct (DBP) 
during chlorination and chloramination [13-16]. Disinfectants, such as chlorine, 
ozone, chlorine dioxide or chloramines, react with naturally occurring organic matter 
or anthropogenic contaminants to produce NAs [13-19]. The presence of NAs in 
drinking water can also result from contamination by industrial and/or agricultural 
sources [13, 20], or from anion exchange resins [21] (i.e., anion exchange resins used 
to remove anionic contaminants can produce higher NA levels in finished products). 
The US EPA estimates a 10
-6
 cancer risk of 0.2–20 ng/L for most nitrosoamines in 
drinking water and unregulated contaminant monitoring minimum reporting levels 
(UCMRL) range from 2 to 7 ng/L. Analysis of NAs at these concentrations is 
extremely difficult, requiring sophisticated instrumentation and laborious sample 
preparation techniques. Therefore, there is the need to develop a simple method that is 
capable of analyzing one or more NAs as a probe for indicating the presence of NAs 
(i.e., NAs are not typically found in isolation), to mitigate the cancer risk among the 
populace across the US and beyond. The specific objective of this work was to 
develop an ICE Concentration Linked with Extractive Stirrer (ICECLES)-gas 
chromatography (GC-MS) analysis method to detect nitrosodipropylamine, NDPA, 
(MRL = 7 ng/L) as a probe for NA contamination.  
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Chapter 2 reports the determination of available Cbi via liquid chromatography- 
tandem mass spectrometry (LC-MS-MS). Chapter 3 details the ICECLES-GC-MS, a 
novel method that has the ability to detect concentrations of NDPA below the EPA 
minimum reporting limits (MRL) levels without using expensive and sophisticated 
instrumentation, such as high resolution GC-MS or GC-MS-MS or LC-MS-MS. 
Chapter 4 details the broader impacts and benefits of this study as well as conclusions 
and future directions. 
1.2.History, Uses and Exposure to Cyanide 
Cyanide was first isolated from Prussian blue dye in 1786, and later extracted 
from almonds around 1800. In about 1815, Gay-Lussac identified cyanide as a 
colorless and poisonous gas having a characteristic almond-like smell/flavor. He 
named it cyanogen.  
  1.2.1. Criminal Uses of Cyanide 
Cyanide is a common chemical for suicides and homicides. The malicious use 
of cyanide has been well-recorded. In November 18, 1978, about 913 members of 
People’s Temple in Jonestown, Guyana, were murdered by Jim Jones after giving the 
members a punch laced with cyanide [22]. Seven (7) people in September 29, 1982 
were killed when cyanide was added into Tylenol capsules [1, 23]. This led to modern 
“tamper-proof” packaging ubiquitous in the pharmaceutical industry. The murder of a 
dry-cleaning owner, Urooj Khan, by cyanide occurred just a day after he won lottery 
in July 20, 2012 [24, 25]. The killing of physician Dr. Autumn Klein in April 20, 
2013 by her husband, Robert Ferrante [26], was perpetrated with a cyanide-laced 
energy drink. Cyanide fishing, a practice whereby sub-lethal doses of cyanide are 
used to stun fish for easy catch is also another illegal use of cyanide [1]. Some 
planned but failed uses of cyanide for criminal purposes includes the purported use of 
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cyanide in cloud bombing at the World Trade Center by Ramzi Yousef, the Philippine 
Airlines Flight 434, the attempted poisoning of water supplies to the US embassy in 
Morocco in 2002, and the planned of dispersing of cyanide gas through indoor 
ventilation systems by alQaeda terrorists as reported by US Department of Homeland 
Security in 2003 [27, 28]. In the 1995 Tokyo subway attack that caused over 5000 
injuries and 12 deaths [1, 27], cyanide gas precursors were found in the subway 
washrooms, where the perpetrators had intended to use both cyanide and sarin for the 
attack [1, 29, 30].  
  1.2.2. Cyanide as a Chemical Warfare Agent 
Chemical warfare agents are defined as any chemical substance whose toxic 
properties are utilized to kill, injure or incapacitate an enemy in warfare and 
associated military operations [31, 32]. CWAs are mostly synthetic chemicals that are 
highly toxic, with fast rapid onset of action, and are generally imperceptible to the 
senses [27]. Cyanide is a considered blood agent because its mode of action entails 
prevention of normal oxygen utilization by the tissues [27, 31]. Hydrogen cyanide 
(HCN) and cyanogen chloride (CNCl) [inclusively referred to as cyanide] are the 
most common CWAs of the blood agent class, and were first used by the French as a 
CWA in the battle of Somme in 1916 [28, 33]. Zyklon B gas (HCN) was used by the 
Nazis during World War II to kill millions of innocent civilians [27, 28, 30]. Cyanide 
was also used as a CWA during the Iran–Iraq war from 1983-1988 [28]   
  1.2.3. Industrial Uses of Cyanide 
Worldwide, over 1 million tons of hydrogen cyanide are produced annually for 
legitimate purposes and approximately 0.9 million tons of this are used in the United 
States [1, 2]. Cyanide is mostly used in plastic manufacturing, photographic 
developing, metallurgy, adhesives, computer electronics, fire retardants, cosmetics, 
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some dyes, some pharmaceuticals, and in ship fumigation [1, 2, 34, 35]. Cyanide is 
also used for metal mining (e.g., gold and silver ores), metal cleaning/polishing, 
production of triazines for agricultural herbicides, production of adiponitrile for 
nylon, and in making rocket propellant [2, 24, 34]. Other uses include the production 
of methionine for animal feed supplements, and the production of chelating agents 
such as nitrilotriacetate for water and waste water treatment [36, 37]. Some 
derivatives of cyanide, such as sodium ferrocyanide and ferric ferrocyanide, are used 
as road salts to serve as anticaking agents [36-38].   
   1.2.4. Potential Sources of Cyanide and Exposure 
The sources of cyanide can be natural or anthropogenic [34].  Exposure of 
cyanide in any form can occur through inhalation (such as smoke from cigarettes or 
fires), ingestion of cyanogenic compounds (e.g., cassava, almonds, lima beans etc.), 
dermal absorption (e.g., occupational hazards, i.e., coming into contact with cyanide 
at the workplace and by parenteral administration (such as the administration of 
sodium nitroprusside for vasodilation) [34, 39, 40]. 
1.2.4.1. Natural Sources of Cyanide 
Cyanide is ubiquitous in nature and can be produced in certain plants, bacteria, 
fungi, and algae [34, 41-43]. Most natural sources of cyanide emanate from 
organocyanide complexes (i.e, organic compounds that has part of it as cyanide 
functional group attached to a carbon atom by way of covalent bonding, e.g., such as 
acetonitrile).  Under normal environmental conditions, there are over 2650 
cyanophoric plant species (of about 550 genera and 130 families) (Figure 1.1) to 
produce cyanogenic glycosides and HCN as a natural defense mechanism (typically 
against herbivory and pathogenic attack). Cyanogenesis may also occur when a plant 
is damaged or stressed [43]. Most glucosidic cyanogens are produced naturally from 
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amino acids (e.g., lotaustralin from isoleucine, linamarin from valine, amygdalin and 
prunassin from phenylalanine, and dhurin from tyrosine) [42].  Some examples of 
cyanogenic plants include plants with significant economic and commercial value 
such as cassava, lima beans, corn, forage materials (e.g., alfalfa, sudan grasses, and 
sorghum), stone fruits (e.g., apricots, apples, peaches), and horticultural plants (e.g., 
ornamental cherry and cherry laurel). Cassava, a common tropical staple food in most 
African countries, contains about one-half the lethal dose of cyanide if consumed 
daily [42], and it has been associated with the neurological disease known as Konzo 
[44-51]. Cyanides are also produced by almost all fruit-bearing plants during ethylene 
synthesis and nitrile metabolism [34, 43, 52]. Some nitriles can also be found in shale 
oils, as plant growth hormones or as a product of cyanohydrins. Some species of 
fungi, such as Clitocybe, Marasmius, Pholiota, Polyporus, and Tricholoma are 
capable of undergoing fungal cyanogenesis to produce hydrogen cyanide. In fact, the 
first production of cyanide by microbes was reported in Marasmius oreades by von 
Lösecke in 1871 [42]. Other types of microbes that produce cyanide are some strains 
of the bacteria pseudomonads and Chromobacterium violaceum, as well as the algae 
Chlorella vulgaris [42, 43, 53, 54]. Also, HCN is present in the earth’s atmosphere, 
and has been detected in the troposphere and the stratosphere [43]. 
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Figure 1. 1. Cyanogenesis in Plants [43]. 
 
1.2.4.2. Production of Cyanide 
Cyanide in its various forms is directly produced or is used as a raw 
material/precursor for the production of other compounds. An increasing amount of 
HCN has been produced in the industry over recent years, as shown in Figure 1.2 
[43]. Cyanide is produced by the Andrussow process (a three-step process where 
ammonia, natural gas and air are reacted in the presence of  platinum catalyst to form 
HCN) or the Blausaure Methane Anlage (BMA) process (which involves the use of 
ammonia and natural gas for the production of cyanide) [55]. HCN is very important 
in industry because it is the main precursor for the manufacturing of methyl 
adiponitrile, methacrylate for polymer manufacturing, cyanuric chlorides, chelating 
agents, and sodium/potassium cyanide for hydrometallurgy of minerals  [34, 55]. 
Apart from the sources listed above, cyanide can also be emitted from iron and steel 
production, carbon black production, carbon fiber production, and petroleum refining 
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[55]. The number of workers exposed to cyanide are estimated as follows: 4,005 to 
hydrogen cyanide, 66,493 to sodium cyanide, 64,244 to potassium cyanide, 3,215 to 
potassium silver cyanide, 3,606 to calcium cyanide, 22,339 to copper (I) cyanide, and 
1,393 to cyanogen chloride [34]. An example of an occupational exposure was the 
August 12, 2015 warehouse explosion in Tianjin, China [56-58], where an explosion 
occurred in a warehouse containing cyanide, and 114 people were killed, 700 injured, 
and 69 were declared missing [58]. 
 
Figure 1. 2. HCN production from 1983 to 2001 [43]. 
 
1.2.4.3. Environmental Sources of Cyanide 
Potential sources of cyanide in the environment are wide-ranging, and include 
natural sources such as cyanogenic plants or anthropogenic sources, including 
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discharges from industrial processes, cyanogenic drugs, laboratories, fires, chemical 
warfare operations, and cigarette smoke.  
It is estimated that cyanide emissions are about 44 million pounds/year. The 
main source of cyanide is from car/automobile exhausts. Other cyanide sources 
include chemical processing (e.g., methyl methacrylate, acrylonitrile, hydrogen 
cyanide, and municipal waste incinerators), metabolic or biogenic processes from 
microbes such as fungi and bacteria, and higher plants also release hydrogen cyanide 
into the atmosphere. In addition, biomass burning contributes about 1-3 billion 
pounds of cyanide/year in the form of hydrogen cyanide and acetonitrile according to 
field measurements and modelling estimates [43].  
A significant source of cyanide in water and soil is from accidental leaks from 
heap leaching pads from the gold mining industry [43]. Examples include the release 
of over 1 billion gallons of cyanide bearing tailings due to a dam failure in Guyana in 
1995, 7 million gallons of cyanide from a storage pond to the Beaver Dam Wash in 
Utah in 1995, and the over 250,000 gallons of cyanide solution from a heap pad in a 
Gold Quarry Mine in Nevada, 1997 [43]. The release of cyanide into aquatic systems 
may occur from discharges from point sources such as publicly owned treatment 
works (POTWs), the organic chemical industry, and the iron and steel industry. 
Nonpoint sources are mainly from agricultural, road runoff, and atmospheric fallout 
[34, 59].  
The largest sources of cyanide in soil are from landfills and anticaking agents. 
Cyanide can also be released into the soil through natural biogenic processes of 
bacteria, fungi, and cyanogenic plants as well as by way of decay of plant tissues from 
the Brassica family [34]. 
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1.2.4.4. Iatrogenic Sources of Cyanide 
Cyanide exposure can occur when taking sodium nitroprusside (SNP) as 
antihypertensive drug for a prolonged period of time [39, 60-62]. Usually, 
nitroprusside is administered intravenously to reduce peripheral blood pressure by 
vasodilatation (by the release of nitric oxide, NO), and also to control bleeding during 
surgery [63-66]. However, SNP contains about 44% cyanide by molecular weight, 
which, can be released upon administration [39, 63, 67-69]. The liver enzyme 
rhodanese is capable of converting cyanide to the innocuous thiocyanate. However, 
toxicity may occur if the administration is prolonged or there is a defect in cyanide 
metabolism, such as impaired renal function, thiosulfate deficiency, or rhodanase 
deficiency [39]. The toxicity of sodium nitroprusside can be eliminated when other 
therapeutics such as a sodium thiosulfate and or sodium nitrile are co-administered 
[61, 63, 70]. Another Iatrogenic source of cyanide is from succinonitrile, a commonly 
used drug in Europe, as an antidepressant [71] and laetrile, an anticancer drug [39, 72-
78]. 
1.3.Fate and Toxicity of Cyanide 
Cyanide forms stable and reversible complexes with biologically active metal ions 
in metalloenzymes (e.g., cytochrome c oxidase, peroxidase, nitrogenase, etc.), and 
consequently inhibits the function of the enzymes. Furthermore, the cyanide can 
inhibit the function of some non-metalloenzymes, such as ribulose diphosphate 
carboxylase [71]. The main cause of cyanide toxicity is a result of binding cyanide 
with cytochrome c oxidase a3 (the ferric iron atom), a terminal oxidase of the 
mitochondria electron-transport chain (ETC), and consequently blocks oxidative 
phosphorylation [79]. Cytochrome c oxidase is the primary source of energy 
production in the form of ATP (Adenosine triphosphate). It facilitates a series of 
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electron and proton transfer from O2 to produce water [34, 40, 80], as shown in Figure 
1.3 [81]. NADH delivers electrons and protons initially to complex I, which in turn, 
are transported throughout the electron-transport chain (ETC) via complex I through 
IV.  As the electrons are transferred, protons are sequentially pumped to the cytosolic 
side of the inner membrane, creating an electrochemical gradient. The electrochemical 
gradient generates a membrane potential that is harnessed by ATP-synthase to 
produce ATP [40, 82]. The net reaction in the cytochrome c oxidase a3 (complex IV) 
in transport of electrons and protons is shown in Equation 1.1 [82]. The transfer of 
electrons to O2 is the terminal step for oxidative phosphorylation. When cyanide 
interacts with cytochrome c oxidase a3, it binds with the trivalent iron in the enzyme, 
and inhibits the activity of the enzyme complex, leading to anaerobic respiration 33  
[34, 82]. To compensate, excess pyruvate is produced, but cannot be channeled 
through the ETC [81-83]. This results in the production of excess lactic acid via 
anaerobic metabolism, leading to metabolic acidosis, and decreased pH in the body. 
The anaerobic metabolism may also lead to progressive histotoxic hypoxia, oxidative 
stress (from production of excess reactive oxygen species, ROS), cytotoxic anoxia, 
and cell death [5, 39, 40, 83-88].  
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 Figure 1. 3. Electron transfer mechanism and the generation of proton-motive force 
required for oxidative phosphorylation to take place in the mitochondria. Four 
protons, known as the ‘chemical protons’ (since they are ‘participants’ of the reaction) 
are taken up from the matrix side to oxygen. At the same time, four additional protons 
are transported from the matrix side into the cytosol (cytoplasm) to bring about the 
electrochemical gradient that is required for the production of ATP through 
bioenergetics-coupled reactions [82].  
 
4𝐶𝑦𝑡𝑐𝑟𝑒𝑑 + 8𝐻𝑚𝑎𝑡𝑟𝑖𝑥
+ + 𝑂2 → 4𝐶𝑦𝑡𝑐𝑜𝑥 + 2𝐻2𝑂 + 4𝐻𝑐𝑦𝑡𝑜𝑝𝑙𝑎𝑠𝑚               
+ (1.1) 
 
In Equation 1.1, Cytcred and Cytcox, refers to the reduced and the oxidized 
form of Cytochrome oxidase a3, respectively. A CN-bound cytochrome c oxidase 
cannot be reduced, and cellular oxygen utilization is impaired. Consequently, aerobic 
respiration is reduced or stopped [81, 84, 86]. 
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1.3.1. Absorption of Cyanide 
The major route of cyanide absorption is through the gastrointestinal tract and 
the respiratory system, with minimal dermal absorption [34, 40, 55, 84]. Cyanide is 
absorbed readily in the gastrointestinal tract but the rate of absorption across the 
gastrointestinal mucosa depends on a number of factors such as the pH of the gut, the 
solubility and the form of cyanide [40]. Usually, small, neutral and non-ionized 
compounds are readily absorbed by biological membranes. NaCN and KCN are easily 
dissolvable, and can be absorbed in the stomach-post ingestion. Also acidic conditions 
in the stomach enhance the absorption of hydrogen cyanide (pKa of 9.2 at 25 °C) [34, 
40]. HCN is mostly absorbed after inhalation, where it instantly passes through the 
alveolar epithelium of the lungs [34, 40]. 
   1.3.2. Distribution of Cyanide 
Once cyanide enters the body and is absorbed, it is distributed throughout the 
body, with targeted tissues being those that have the highest oxygen demand (e.g., 
heart, brain, liver, kidney, stomach). The brain and the heart are the primary target 
organs in acute cyanide intoxication, with characteristic symptoms, such as 
convulsion, impaired respiratory activity, and cardiovascular difficulties. Also, 
elevated cyanide levels can be measured in absorptive tissues, such as lungs (when 
cyanide is exposed via inhaling) and stomach (when cyanide is orally ingested) [34, 
40, 55]. Approximately 60% of absorbed cyanide binds to proteins, and has high 
affinity for transition metals, such as iron and cobalt [84]. 
   1.3.3. Acute Effects of Cyanide 
Acute and subacute effects of low-level cyanide may result in lactic acidosis, 
progressive anorexia, anxiety, weak and rapid pulse rate, nausea, and vertigo [34, 43, 
71]. The symptoms progress to irregular heartbeats, cardiac arrhythmias, drop in body 
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temperature, cyanosis of lips and face, and sometimes, frothy bloody saliva from 
mouth, and death [34, 39, 71, 83]. For humans, inhalation of about 110 to 135 ppm of 
cyanide may result in death within few hours, while an inhalation of about 220 to 270 
ppm causes death in minutes [71]. 
  1.3.4. Chronic Effects of Cyanide 
Chronic effects of cyanide are systemic and can include neurological, 
respiratory, cardiovascular, and hepatic disorders [34, 71]. Chronic cyanide exposure 
leads to neuropathic and thyrotoxic disorders [52, 71]. 
Brain areas that control skeletal muscle activity (i.e basal ganglia, cerebellum), 
memory (hypothalamus), and cognitive ability (cortex) are the most effected parts of 
the central nervous system from cyanide poisoning [43]. Human neuropathies 
associated with nonlethal chronic cyanide exposure of low cyanide levels includes 
Nigerian nutritional neuropathy (tropical ataxic neuropathy, TAN), Konzo, tobacco 
amblyopia, and Leber’s optical atrophy [34, 71, 89]. Neurological effects of cyanide 
poisoning are mainly due to the blockage of mitochondrial cytochrome c oxidase 
activity, leading to rapid biochemical changes in the brain, such as  changes in ion 
flux, neurotransmitter release (both excitatory and inhibitory), peroxide formation, 
and decrease in the ATP/ADP ratio required for cellular calcium homeostasis [34, 43]. 
The cardiovascular system is an important site for cyanide toxicity [43]. 
Specific cardiovascular symptoms of cyanide exposures include hypotension, 
supraventricular tachycardia, atrioventricular blocks, ventricular fibrillation, and 
asystole [34, 39]. Cyanide toxicity also alters respiration due to inadequate cellular 
oxygen utilization, leading to deficit in traditional global oxygen consumption/oxygen 
saturation curve [78, 90]. Respiratory effects of cyanide toxicity include coughs, sore 
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throat, nasal congestion, epistaxis, hemoptysis, dyspnea, apnea, decrease in 
respiratory rate/hypoventilation, and asphyxia [34, 39]. 
1.4. Cyanide Antidotes 
Cyanide has several antidotes that have different mechanisms of 
action/pharmacokinetics, clinical effects, and risk-benefit profiles. Cyanide antidotes 
include the Nithiodote (which contains sodium nitrile and sodium thiosulfate) and 
Cyanokit (hydroxocobalamin). Dicobalt-ethylenediamine tetraacetic acid (dicobalt 
Edetate) and 4-dimethylaminophenol (4-DMAP) are used to a lesser extent due to 
their relatively significant contra-indications [6, 39, 84, 91-93]. 
   1.4.1. Clinical Properties of Ideal Cyanide Antidotes 
A cyanide antidote that meets the need of a victim in acute exposure of 
cyanide should have some important properties, including 1) rapid onset of action, 2) 
capable of neutralizing cyanide without interfering with cellular oxygen use or 
transport, 3) conducive safety and tolerability profiles in pre-hospital settings and 
emergency situations, 4) safe for use with victims with smoke inhalation, 5) not 
harmful when administered to non-poisoned patients and 6) easy to administer, 
especially in mass casualty situations [91, 93]. Table 1.1 [91] shows some cyanide 
antidotes and their ability to satisfy these ideal qualities. 
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Table 1. 1. Selected cyanide antidotes and their suitable qualities as cyanide antidotes 
[91]. 
Quality CAK 
Na2S2O3 
alone 
4-
DMAP 
Dicobalt 
edetate Cbl 
Rapid onset of action Yes No Yes Yes Yes 
Neutralize CN without compromising 
oxygen-carrying capacity No Yes No Yes Yes 
Tolerability and safety profile conducive 
to prehospital use No Yes No No Yes 
Safe use in smoke-inhalation victims No Yes No No Yes 
Not harmful when administered to non-
patients No Yes No No Yes 
Easy to administer No Yes Yes Yes Yes 
 
 
1.5.   1.4.2. Mechanism and General Classes of Cyanide Antidotes 
 The current US FDA approved cyanide antidotes are sodium nitrite, sodium 
thiosulfate, and hydroxocobalamin [6, 30, 35, 39, 56, 84, 91, 92, 94-96]. 
1.4.2.1. Methemoglobin generators 
A methemoglobin generator, such as sodium nitrite, reverses cyanide 
poisoning by interacting with hemoglobin (Hgb) to form the oxidized Hgb, 
methemoglobin (MetHgb). CN has low affinity to Hgb but has relatively high affinity 
to MetHgb. Consequently, CN reacts with MetHgb to form cyano-MetHgb complex 
(Scheme 1.1), which can be facilely excreted via urine [84, 91, 92].  Although nitrite 
activity is mainly attributed to the formation of MetHgb, recent studies suggest that 
nitrite-mediated conversion of Hgb to MetHgb is too slow to account for cyanide 
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antagonism [96]. It has been proposed recently that another mechanism of action 
accounts for the nitrite’s antidotal activity; nitrites induce the generation of nitric 
oxide, which subsequently displaces cyanide bound to the active site of cytochrome c 
oxidase [84, 95-97], which restores the activity of cytochrome c oxidase. The 
displaced CN may be scavenged by circulating MetHgb, or converted to SCN [84]. 
However, methemoglobenimia produced by nitrite reduces the oxygen saturation level 
and transport. This is a serious condition for victims who are exposed to cyanide 
through smoke inhalation, where the formation of carboxyhemoglobin occurs, in 
addition to methemoglobenimia. As a result, administration of sodium nitrite is 
followed by careful observation of victims’ oxygen level, and constant oxygenation. 
Another disadvantage of sodium nitrite administration is that it requires intravenous 
administration.  Thus, the main challenges of sodium nitrite administration as a 
cyanide antidote are its contra-indication exhibited by compromising oxygen 
transport, and difficulty with mode of administration, requiring special skill for 
administration [91]. 
NaNO2  +  HgbO2 MetHgb
MetHgb  +  CN-CytC CN-MetHgb  +  CytC  
Scheme 1. 1. Sodium nitrite (NaNO2) helps in scavenging cyanide. Fe
2+
 in the 
oxyhemoglobin is oxidize to Fe
3+
 in MetHgb. Formation of large amounts of Methgb 
with its concomitant trivalent ferric iron has relatively high affinity for cyanide, and 
so binds cyanide more than cytochrome c oxidase (CytC) [56, 98]. 
 
1.4.2.2. Sulfur Donors 
Sulfur donor-based antidotes, such as sodium thiosulfate (Na2S2O3) detoxify 
cyanide by first donating sulfur (S) to Rhodanese (Rh) to form S-Rh [92, 95]. The 
sulfur-bound Rh then reacts with the CN to form SCN
-
 (Scheme 1.2) [99], which is 
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easily excreted in the urine. CytC Oxidase activity is restored in this process and 
aerobic respiration resumes [39, 91, 92]. However, Rh is predominantly located in the 
mitochondrial matrix of the liver and kidney but limited in the central nervous system 
(brain) and heart, leaving these two important organs relatively unprotected [40, 56, 
91, 92, 95]. In addition, Na2S2O3 has slow onset of action due to limited penetrability 
through the mitochondrial membranes to the enzyme Rh. Furthermore, Na2S2O3 
requires intravenous administration [6, 56, 60, 84, 92, 95].  
 
k+1
k-1
Rh(SSO3
-)
k+2 Rh-S +  SO3
-
Rh + SSO3
-
Rh-S + CN-
k+3 SCN- + Rh
 
Scheme 1. 2. Rhodanese enzyme reaction with CN to produce SCN
-
. Mechanistically, 
the reaction goes through a double replacement process to catalyze the detoxification 
of cyanide by sulfuration [40, 99, 100]. The free enzyme (Rh) reacts with a sulfane 
sulfur donor (e.g.,SSO3
-
) to cleave the S-S bond to form the persulfide-substituted 
enzyme, Rh-SSO3
-
. The Rh-SSO3
-
 then reacts with sulfur acceptor substrate (CN
-
) to 
form the innocuous thiocyanate, SCN, and regenerates the enzyme, Rh [40, 99].    
 
1.4.2.3. Direct Binding Agents 
The only FDA-approved direct binding cyanide antidote is hydroxocobalamin 
[84, 91, 92, 95, 101, 102] (Figure 1.4). Hydroxocobalmin (Cbl) is a hydroxylated 
form of vitamin B 12 [40, 84]. Cyanide has a greater affinity to bind with Cbl than 
cytochrome oxidase a3 [103]. Thus, Cbl directly reacts (non-enzymatically) with 
cyanide to form the cyanohydroxocobalamin (CN-Cbl) (Scheme 1.3), which is renally 
excreted  [101]. Cbl is relatively safe because it does not interfere with oxygen-
carrying capacity of blood, it is not harmful when administered to non-poisoned 
patients, and it is easy to administer for small number of casualties at the site of 
exposure etc. [39, 40, 102, 104]). Even though Cbl is effective, large volumes are 
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required via intravenous administration. Consequently, Cbl is not suitable in mass 
casualty situations [40, 56, 84, 95].  
 
 Figure 1. 4. Chemical structure of hydroxocobalamin, with the nucleotide moiety, 
dimethylbenzimidazole ribonucleotide, shown in blue color. 
 
Cbl  +  CN- CN-Cbl Complex  
Scheme 1. 3. Reaction of hydroxocobalamin with cyanide, without the aid of 
enzymes. Cbl binds cyanide molecule in a 1: 1 mole ratio [105, 106]. 
 
1.4.2.4. Combination Therapies 
In the US, Nithiodote is the only FDA-approved combination therapy. 
Nithiodote is typically administered by intravenous infusion, which is not practical 
when trained personnel are absent and in mass casualty situations [35]. For effective 
and efficient treatment during mass casualty scenarios, the best mode of 
administration should be via intramuscular injection of the antidote by first 
responders, usually from a prefilled autoinjector. For this situation to be feasible, the 
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antidote needs to be stable in solution, sufficiently soluble to be administered in 1-3 
mL doses, needs to be highly potent so that relatively small amount is administered, 
and should be readily absorbed when administered intramuscularly [35, 94]. Sodium 
nitrite and sodium thiosulfate are quite soluble in water, and stable under anaerobic 
conditions, and are typically effective when administered intravenously. However, 
current work by Bebarta et al. [94] shows that Nithiodote has some activity against 
cyanide when administered by intramuscular injection. 
When studying other combination therapies, Berbata et al. [107] showed that 
hydroxocobalamin with sodium thiosulfate led to faster return to baseline mean 
arterial pressure compared with administration of sodium nitrite with sodium 
thiosulfate. There was no significant difference in mortality, serum acidosis, or serum 
lactate for either of the antidote combinations.  Hall and Rumack [108] reported that 
hydroxocobalamin with sodium thiosulfate is an efficacious cyanide antidote with 
little inherent toxicity.  
  1.4.3. Next Generation Cyanide Antidotes 
Since the onset toxicity of cyanide is rapid, there is the need for antidotes that 
are capable of being rapidly administered by minimally trained individuals, especially 
in a mass exposure scenario. Therefore, the development of next generation antidotes, 
which possess better therapeutic indices and efficacy, have a relatively easy mode of 
administration (e.g., intramuscularly or orally), and are equally effective throughout 
the body, is an important priority going forward.  Currently, the most well-studied 
next generation cyanide antidotes under investigation are cobinamide [6, 30, 35, 84, 
93, 105, 109], sulfanegen (i.e., 3-mercaptopyruvate) [6, 84, 92, 95, 96, 105, 110], and 
dimethyl trisulfide [56, 111-114]. Table 1.2 outlines some of these antidotes, each of 
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which can be administered intramuscularly (IM) in mass casualty scenarios, and their 
mode of action [84].  
Table 1. 2. Novel Cyanide therapies in development for rapid IM in mass casualty 
scenarios [84]. 
Novel 
therapy 
Mode of action 
Older 
analog 
Cobinamide Direct binding agent Cbl 
Sulfanegen Sulfur donor (leverages 3 mercaptopyruvate sulfur 
transferase) 
3-MP 
DMTS Sulfur donor (with/without Rhodanese enzyme) NA 
 
 
1.4.3.1.Cobinamide 
Cobinamide is the penultimate precursor in the biosynthesis of cobalamin 
(Cbl). Structurally, Cbi is similar to Cbl but Cbi lacks dimethylbenzimidazole 
nucleotide tail moiety [6] that is coordinated to the cobalt atom in the lower axial 
position of the Corrin ring (Figure 1.5). The lack of the dimethylbenzimidazole 
ribonucleotide in Cbi makes it possible for it to have a second free binding site, and 
prevents the trans site steric hindrance associated with the dimethylbenzimidazole 
group [30, 79, 84, 109, 115-120]. Consequently, Cbi has relatively smaller mass [6], 
and a mole of Cbi binds to two moles of cyanide (1 mole Cbl binds to only 1) with an 
overall cyanide binding affinity of 10
22
 M
−2 
(10
12
 mol/L for Cbl) [117-119]. Another 
therapeutic advantage of Cbi includes its relative solubility (about 5 times than Cbl), 
and stability at room temperature, as well as its ability to be administrated 
intramuscularly [35, 93, 105, 109, 116]. Cbi is the generic term used for 
diaquocobinamide [(H2O)2Cbi
2+
] or its conjugate base, hydroxoaquocobinamide 
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[(OH)(H2O)Cbi
+
] [117, 119]. Cbi binds strongly to transmembrane proteins, placing a 
challenge on its distribution [121, 122]. However, the dinitrocobinamide form 
[(NO2)2Cbi] [6, 35] and the sulfite form [(SO3)2Cbi] [93] had been reported to be 
fairly distributable in biological system.  Research by Broderick et al. [115] revealed 
that Cbi was several-fold more effective than Cbl in (i) reversing cyanide inhibition of 
oxidative phosphorylation in mammalian cells; (ii) rescuing mammalian cells and 
Drosophila melanogaster from cyanide toxicity; and (iii) reducing cyanide inhibition 
of Drosophila Malpighian tubule secretion. Brenner et al. [93, 116] also showed that 
Cbi was better at reversing cyanide toxicity than Cbl in cyanide exposed animals. 
Adriano et al. [105] reported that Cbi has a higher affinity for nitric oxide than Cbl, an 
additional advantage for Cbi’s greater efficacy as a cyanide antidote. Nitric oxide has 
the ability to regulate the activity of cytochrome c oxidase, the main cyanide target.    
   
 Figure 1. 5. Structure of cobinamide without any ligands attached, and lacking the 
dimethylbenzimidazole ribonucleotide (as in Cbl in Figure 1.4).  
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1.4.3.2. Sulfanegen/3-Mercaptopyruvate (3-MP) 
Sulfangen, a prodrug of 3-MP (i.e., sulfanegen converts to 3-MP upon 
administration), is a potent cyanide antidote. 3-MP is a sulfur donor that converts 
cyanide to thiocyanate by utilizing the ubiquitous cyanide detoxifying enzyme, 3-
mercaptopyruvate sulfur transferase (3-MPST) [6, 84, 92, 95, 96, 123], as outlined in 
Scheme 1.4 [92].  3-MPST is relatively more widely distributed in tissues, including 
the central nervous system, and can be found both in the mitochondria and the 
cytosol. These features of 3-MPST make it more advantageous for efficient 
detoxification of cyanide than rhodanase (which is limited in distribution and found 
only in the mitochondria) [6, 92].  Similarly to rhodanese, the mechanism of reaction 
of 3-MPST involves generation of an enzyme-persulfide intermediate (3-MPST-3MP) 
that reacts with cyanide to produce thiocyanate, and regenerates the free enzyme, 3-
MPST [96]. The sulfur donor for the 3-MPST is from the cysteine catabolite 3-MP 
and the site of the persulfide formation is postulated to take place at Cys248 [96]. 
However, 3-MP decomposes rapidly and facilely in the blood. Therefore, to ensure 
continuous supply, an intramuscular administration of sulfanegen is required for 
cyanide detoxification [84, 92]. Interestingly, current research work by Chan et al. 
[105] shows that combination of cobinamide and sulfanegen, when administered 
intramuscular, gives a great promise as a new approach to treating cyanide poisoning. 
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Pyruvate
Thiocyanate
 
Scheme 1. 4. Structure of sulfanegen sodium and the enzymatic transfer of sulfur 
from 3-MSPT to pyruvate with concomitant conversion of cyanide (CN) to the 
innocuous thiocyanate (-SCN) [92]. 
 
1.4.3.3. Dimethyltrisulfide (DMTS) 
Dimethyl trisulfide (DMTS), is a promising next-generation cyanide antidote 
that functions by acting as a sulfur donor to detoxify cyanide by converting it into 
thiocyanate with or without rhodanese [56, 124]. The proposed mechanism for the 
detoxification of cyanide by DMTS via rhodanese is well enumerated, but the non-
enzymatic routes are not as well-understood [56]. Compared to thiosulfates, a recent 
study shows that DMTS is about 40 times more effective than thiosulfates in-vivo in 
the presence rhodanese, and about 80 times more efficacious than thiosulfate via non-
enzymatic routes. In addition, studies by Kiss et al. [124] revealed that DMTS has 
better efficacy than the Cyanokit (hydroxocobalamin) and the Nithiodote (sodium 
nitrite and sodium thiosulfate) therapies. The main therapeutic feature of DMTS is its 
relatively high lipophilicity, making it possible to facilely cross the blood brain barrier 
[56]. It can also be administered intramuscularly [112, 125] and provides 
cardiovascular protection [124]. However, recent studies by Dong et al. [126] shows 
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that DMTS does react slowly with Hgb to form MetHb. They suggested that the 
reaction of DMTS and Hgb could explain the lower recoveries of DMTS from fresh 
blood in which the Hb/metHb ratio was higher than in aged blood.  
1.5.  Analytical Methods For Detection of Cobinamide derivatives in Biological 
Fluids  
 Several methods, including colorimetric techniques, HPLC, UV, ICP-MS, and 
currently HPLC-MS-MS have been used to analyze Cbi and its derivatives [6, 118, 
127-131]. Absorbance-based techniques have relatively low sensitivity. The ICP-MS 
method produces quite good sensitivity but lacks the method efficiency and detection 
limit for the sample size expected, and complex sample matrix [118].  Alsberg et al. 
[132] developed a method for the analysis of hydroxyalkyl derivatives of cobalamin 
(i.e., hydroxypropyl cobalamine, OH-PrCbl), using HPLC with ESI-MS-MS and 
ultraviolet diode array detection (UV-DAD). One of the methods made use of two 
different mobile phases (eluent A and B, respectively) and two column systems: 
Eluent A was acetonitrile and water with trifluoroacetic acid (TFA) added to a 
concentration 0.4 mM (ACN/water with TFA), and Eluent B was made up of 
ACN/water with 1-methylpiperidine. Column I and II used were Kromasil C18 (4.6 
mm x 250 mm, 5 mm), and Zorbax C18 (2.1 x 150 mm, 3.5 mm), respectively. The 
limit of detection obtained was 0.2 pg/mL. The analytical method by Schwenter et al. 
[133] involved an LC-MS-MS method for the detection of hydroxocobalamin 
(HOCbl) and cyanocobalamin (CNCbl) in swine plasma, obtaining an LOD of 1.0 μM 
each for HOCbl and CNCbl.  An online SPE HLB column (2.1 mm × 20.0 mm, 
25 μm) was used for extraction, while a C18 Phenomenex Luna analytical column 
(2.0 mm × 150 mm, 5 μm) was used for the analytical separation. Mobile phase A 
consisted of 2.5 mM ammonium acetate in 50:50 methanol:water, (pH 4.0), and 
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solvent B was 10% acetonitrile in water.  Similarly, Mendes et al. [134] performed 
pharmacokinetic studies for HOCbl in human plasma using HPLC-ESI-MS-MS. The 
samples were extracted from the plasma by liquid-liquid extraction using 100% 
ethanol, at -20°C, and separated with Prevail C8 analytical column (2.1×100 mm, 3 
µm). Acetonitrile: water (50:50 v/v) was used as mobile phase A, while mobile phase 
B was composed of 10 mM ammonium acetate with 0.1% formic acid. The limit of 
quantification was 5 ng/mL. McCracken and Brittain [118] also reported an LC-ESI-
MS-MS method for the analysis of total cobinamide in swine plasma, following Cbi 
‘total’ conversion to dicyanoCbi with excess cyanide in swine plasma. The lower 
limit of quantification was 25 ng/L. The separation of the analyte was performed 
using a Phenomenex Kinetex C18 column (2.1 × 150 mm, 2.6 µm). The mobile phase 
composition was 0.01% formic acid in water (A) and 0.01% formic acid in 
acetonitrile (B). Stutelberg et al. [6] gave the first comprehensive method for the 
simultaneous analysis of cyanide antidotes Cbi and 3-MP using LC- ESI-MS-MS. The 
sample preparation protocol for the Cbi was similar to that reported by McCracken 
and Brittain. Separation was performed by using a Phenomenex Synergy Max RP 
column (2.0 × 50 mm, 4 μm ) with the elution aided by 5-mMaqueous ammonium 
formate with 10% methanol (Mobile Phase A) and 5-mM ammonium formate in 90% 
methanol (Mobile Phase B). This analytical method produced an LOD of 0.2 µM and 
a linear range of 0.5 to 50 µM with excellent precision and accuracy. 
1.6. History, Formation and Exposure to Nitrosoamines 
 Most nitrosoamines are relatively polar (i.e., very soluble in water with low 
log Kow) and have very small Henry’s constants (Table 1.3) [16]. The low log Kow of 
NAs makes it difficult to extract them with organic solvents, and the small Henry’s 
constants is an indication that they cannot be removed from water by aeration [16].   
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Table 1. 3. Some physical and chemical properties of some NAs [135].  
Name 
Chemical 
Structure 
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As early as the 1950s, analytical methods were developed for NAs because they 
were suspected to be generated after adding nitrites as a meat preservative. Nitrite is 
added to most meat to prevent the growth of Clostridium botulinum, and this leads to 
high concentrations of NAs in bacon, sausage, and ham, but low in unprocessed meat 
and salted fish [136]. Nitrosamines are formed in food when organic amines or their 
derivatives react with nitrosating compounds. Besides food, NAs or their precursors 
can be found in air, water, pesticides, herbicides, cosmetics, tobacco, and packing 
materials [136-139].  Several studies in the US revealed that NAs can be formed at 
drinking water treatment plants (DWTPs) and in their distribution systems, as 
disinfection by-products. There are several ways by which nitrosomaines are formed 
in water. Chloroamination is the major cause of NAs formation in drinking waters, 
and amine forms the major precursor during the chloramination. It is important to 
state that chloroamination is the low-cost option approved by the USEPA (Stage 2 
DBP rule 2) for controlling trihalomethane and other disinfection  by-products 
(DBPs) [15]. However, studies have shown that about 5% of chloramine is in 
dynamic equilibrium with dichloramine, which then reacts with secondary amines to 
form the corresponding NA, as outlined in Scheme 1.5 [15, 140]. Mechanistically, 
there is a nucleophilic attack on the unprotonated secondary amine on dichloramine, 
yielding an unsymmetrical diakylhydazine intermediate. This is then followed by 
oxidation of the diakylhydazine intermediate in the presence of dissolved oxygen to 
afford the corresponding NA [15, 140]. The reaction is a slow process and it takes 
days to accumulate the NA as a DBP. Another major route for NA formation in water 
is chlorination processes in the presence of dinitrogen tetraoxide (N2O4), an inorganic 
nitrogenous intermediate, which can lead to the nitrosation of amines to form NDMA. 
During ozonation of wastewater or reclaimed waters, NDMA may be formed due to 
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the reactions between trace amine-based organic chemicals and ozone itself. For 
nitrosoamines to form by ozonization and chlorination, a bromide catalyst may be 
required. Nitrosoamines can be formed in water from dissolved organic compound 
precursors, such as dimethyl amine, ranitidine (i.e., a pharmaceutical drug for antacid 
and antihistamine), and quaternary amines (e.g., the polymer polyDADMAC, anion 
exchange resins, and shampoo constituents) [12, 15, 16, 141]. Other minor routes of 
nitrosoamine formation in water include the formation of nitrosating species from a 
nitrogen gas on activated carbon surfaces under aerobic conditions, and sunlight 
photolysis of nitrite or UV photolysis of secondary chloramines [15]. 
 
2NH2Cl  +  H
+ NHCl2   +   NH4
+
HN
CH3
CH3
N
CH3
CH3N
Cl
H
+   HCl
O2
O N N
CH3
CH3
Chloramines
Other products NDMA
(a) (b)
(c)
(d)
(f)  
Scheme 1. 5. Showing the generalized formation of nitrosoamines in water during 
disinfection via chloroamination [140, 142].  (a) monochloramine, (b) dichloramine, 
(c) secondary amine (here, dimethylamine), (d) chlorinated unsymmetrical 
diakylhydrazine (chloro dimethylhydrazine), and (f) the corresponding NA from the 
secondary amine (c) (here, dimethyl nitrosomaine, NDMA is formed). 
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The potential routes of most NA exposures to humans are ingestion, inhalation 
and dermal contact. Food and tobacco products are the major external source of 
human exposure to NAS, while small amount of NAs can also be produced internally 
in the digestive tract [143, 144]. 
1.7. Metabolism, Toxicity, and Heath Effects of Nitrosoamines  
 The metabolism of NAs is catalyzed by cytochrome P-450 or CYP-450, which 
is initiated by the reaction of the monooygenase reaction [137, 139]. Cyclic 
nitrosoamines undergo α-hydroxylation in the presence of cytochrome P-450 or CYP-
450 to yield alkylating agents such as diazohydroxide and carbonium ions. These 
metabolites facilely bind with DNA or may be involved in the generation of 
electrophiles that have the propensity to react or bind with DNA to produce DNA 
adducts, as outlined in Figure 1.6 [139]. The biotransformation of cyclic 
nitrosoamines can also start by β-hydroxylation, but the mechanism is not fully 
understood. In a similar fashion, acyclic or volatile nitrosoamine metabolism proceeds 
solely by an α-hydroxylation to give formaldehyde, which alkylates DNA to form 
DNA adducts or the diazohydroxide binds directly with DNA (Figure 1.7) [139].   
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Cylic nitrosoamines
alpha-hydroxycyclic nitrosoamines
alpha-hydroxylation
or beta-hydroxylation
ring open
formation of the alkylating agent, alkydiazonium hydroxide
may bind directly with
DNA and cause mutation
may react with surronding water molecules
to form various alkylating agents
 
Figure 1. 6. General adduct formation mechanism and metabolism of cyclic 
nitrosoamines [139]. 
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Figure 1. 7. Generalized metabolic route and DNA adduct formation involving 
acyclic nitrosoamines, such as dimethylnitrosoamine [139].  
 
The formation of DNA adducts, or alkyl DNAs, due to the metabolism of 
nitrosoamine leads to defects in the nucleotide base pairing, and consequently results 
in mutations that disrupts cell function, metabolism and synthesis, leading to 
apoptosis and cell damage [139]. 
1.8. Heath Effects of Nitrosoamines  
 The USEPA classified most nitrosoamines, including NDMA, NDEA, NDPA, 
as likely to be carcinogenic to humans by a mutagenic mode of action under the 
USEPA Guidelines for Carcinogen Risk Assessment, based on evidence of 
carcinogenicity in animal studies [135]. The propensity of the metabolites of 
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nitrosoamines to bind cellular DNA leads to mutagenesis and carcinogenesis. These 
carcinogenic and mutagenic metabolites alkylates several sites of DNA such as N-1, 
N-3, N-7 positions of adenine N-3, N-7 and O
6
 of guanine, N-3, O
2
 of cytosine and 
N
3
, O
4
, O
2
 of thymine and the oxygens of the phosphate group. The esophagus, oral 
cavity, and pharynx are some of the reported sites of mortality due to the 
carcinogenic effect of high levels of nitrosoamines [145]. Recent studies show that 
nitrosoamines can also induce colorectal cancer in humans [146]. 
1.9. Current Methods for Analysis of Nitrosoamines in Drinking Water  
 The ‘standard’ methods for the detection and quantitation of most 
nitrosamines (i.e, NDMA, NDEA, NDBA, NDPA, NMEA, and NPYR) in drinking 
water are based on the EPA method 521 and the Standard Methods (SM), 6450B and 
6450C [135].  
 The EPA Method 521 [135, 147], (Version 1.0) is the analytical method that 
describes ‘Determination of Nitrosamines in Drinking Water by Solid Phase 
Extraction (SPE) and Capillary Column Gas Chromatography with Large Volume 
Injection and Chemical Ionization Tandem Mass Spectrometry (CI-MS-MS)’.  It is 
the method approved for use under the second cycle of the Unregulated Contaminant 
Monitoring Rule (UCMR 2) to monitor the six nitrosamines with reference to their 
health reference levels (HRLs) [135].  Essentially, the method involves the pre-
concentration of 0.5 L of a water sample containing a known concentration of a 
surrogate analyte through an SPE cartridge absorbent made of coconut charcoal. 
Elution of the anaylte (and possible contaminants, if present) from the SPE column is 
performed with methylene chloride. The sample is dried, reconstituted, and a suitable 
internal standard is added. The resulting solution is analyzed via GC-CI-MS-MS. The 
detection limits (DL), as well as the lowest concentration minimum reporting levels 
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(LCMRL) associated with this method for most common NAs, are summarized in 
Table 1.4 [135].  SM 6450B also makes use of an SPE absorbent cartridge made of 
granular carbonaceous adsorbent resin that is capable of achieving a concentration 
factor of 500 to 1000, and an MDL between 0.5 to 2.0 ng/L. Method 6450C is an 
alternative method that employs a liquid-liquid microextraction procedure, achieving 
a concentration factor of 200, with MDL, ranging from 2 to 4 ng/L [135]. 
 
Table 1. 4. Some Figures of Merit (Performance metrics) for NA analysis via EPA 
Method 521 [135]. 
Analyte 
DL (ng/L) LCMRL MRL Recovery RSD  
(ng/L) (ng/L) (ng/L) Range (%) Range (%) 
NDBA 0.36 1.4 4 79.7-104 2.9-16 
NDEA 0.26 2.1 5 84.6-95.6 6.5-14 
NDMA 0.28 1.6 2 83.7-94.7 3.8-12 
NDPA 0.32 1.2 7 77.1-97.0 3.7-10.2 
NMEA 0.28 1.5 3 81.4-91.0 4.5-9.6 
NPYR 0.35 1.4 2 85.2-102 4.0-12 
 
 
Similar methods developed by many researches for the determination of NA 
are also based on enrichment of the NA via SPE, followed by methylene chloride 
extraction (elution),  concentrating the eluate to less than 1 mL, and analyzing via 
chromatographic (GC or HPLC) methods with tandem mass spectrometric (MS-MS) 
detection [16]. Charrois et al. [16, 148] made use of an SPE column with dual 
absorbent made of LiChroult EN (bottom layer) and an Ambersorb 572 (upper layer). 
Dichloromethane was used for the elution of the NAs from the column, and the eluate 
were dried with nitrogen to about 200 µL, and analyzed with GC coupled with MS 
detector operating in a PCI mode and ammonia as a reagent gas. A concentration 
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factor of 2500 was obtained.  Similarly, Chen et al. [16, 149] compared three methods 
that basically involved the use of an SPE with Ambersorb 572, a commercially 
available cartridge SPE (CSPE), and a liquid-liquid microextraction system (MLLE).  
For the graphitized black carbon with Ambersorb 572 sorbent system, elution was 
carried out with dichloromethane, followed by solvent evaporation and GC-CI-MS-
MS analysis, giving a concentration factor of 1000. With the MLLE, dichloromethane 
was also used for the extraction to a 0.5 mL and analyzed with same method, giving a 
concentration factor of 200. Planas et al. [150] also employed two different 
approaches (a) Ambersorb 572 and (b) EPA 521 cartridges with gas chromatography 
high-resolution mass spectrometry (GC-HR-MS) to analyze NAs in drinking water. In 
both sample preparation protocols, dichloromethane was used to elute the analytes, 
followed by solvent evaporation with air (for a) or stream of nitrogen gas (b) and 
subsequent analysis with GC-HR-MS. The minimum detection limits obtained with 
this method ranged between 0.08 and 1.7 ng/L.  Recently, a group of scientists at 
Agilent reported a detection limit of 0.038 to 0.332 ng/L when they used the EPA 521 
sample preparation protocol discussed above, and analyze their samples with low 
resolution GC-MS instrument (i.e., the Agilent 5977A series GCMSD) [151].  
Some SPE-HPLC-MS-MS methods have been extensively used for analyzing 
NAs, including methods of Zhao et al. [152], Ripolles et al. [12], Krauss and 
Hollender [16, 153], Qian et al. [18], and Wang et al. [154].  The first LC-MS-MS 
method for the detection of NAs in drinking water was developed by Zhao et al. [152, 
155], using an SPE cartridge packed with 350 mg of LiChrolut EN (bottom layer), 
500 mg of Ambersorb 572 (middle), and glass wool (top). Dichloromethane was used 
to elute the analytes, and the organic eluent collected and concentrated down to 200 
µL under a high purity nitrogen stream in a 40 °C water bath. NDPA-d14 (100 µL of 
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200 µg/L) was added as an internal standard and the analysis was carried out using a 
HPLC-ESI-MS-MS method, obtaining a detection limits of 0.1 to 10.6 ng/L.  Ripolles 
et al. [12] used the EPA 521 SPE sample pre-concentration technique (i.e., coconut 
charcoal EPA 521 cartridges with a 500 mL water sample) and analyzed by LC-MS-
MS with atmospheric pressure chemical ionization (APCI) in positive mode. The 
detection limit achieved with this method was between 1 and 8 ng/L. Krauss and 
Hollender [153] proposed a method for quantifying nine N-nitrosamines in drinking 
and wastewater samples by LC(ESI)MS/HRMS, using a linear ion trap (LTQ)–
Orbitrap hybrid mass spectrometer, and combining Oasis HLB with a carbonaceous 
sorbent for SPE-LTQ (obtaining an LOD of 0.2–3.9 ng/ L).   
Qian et al. [156] developed an SPE-HPLC-MS-MS method where they used a 
cartridge made up of vinyl/divinylbenzene polymer that was used to pre-concentrate 
100 mL of water (instead of 500 mL in other methods), yielding an LOD of 0.01−2.7 
ng/L.  The method developed by Wang et al.[157] involved the use of Resprep EPA 
521 cartridges followed by HPLC-EI-MS-MS, a technique originally published by  
Planas et al. [150] to produce LOD between 0.1 and 0.7 ng/L. 
Solid phase micro-extraction (SPME) techniques have been used in 
conjunction with either GC or HPLC to analyze NAs extensively. Grebel et al. [16, 
158] developed an SPME method coupled with gas chromatography with three gas 
chromatography (GC) detection systems, including nitrogen chemiluminesence 
detection (NCD), nitrogen–phosphorus detection (NPD) and chemical ionization mass 
spectrometry (CI–MS). The LODs associated with this method and others discussed 
above, are outlined in Table 1.5 [16, 135, 148, 149, 153, 158]. Hung et al. [159] 
utilized SPME GC-CI-MS-MS to screen NAs in water, with LODs ranging from 3.2 
to 15.2 ng/L. 
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Table 1. 5. Characteristics of some NA analytical methods. 
Method 
Sample 
Volume 
(mL) 
Sample 
Preparation 
Analysis 
Technique 
LOD 
Range 
(ng/L) 
Estimated 
analysis 
time 
(min) 
Qian et al. [160] 100 SPE 
HPLC-ESI-
MS-MS 
0.01-0.7 120 
You [151] 500 SPE GC-CI-MS 0.038-0.33 360 
Planas et al. [150] 1000 SPE GC-EI-HRMS 0.08-1.7 200
a
 
Krauss and Hollender 
[153] 
500 SPE 
HPLC-ESI-
MS-MS 
0.10-2.40 220 
Zhao et al. [152] 500 SPE 
HPLC-ESI-
MS-MS 
0.1-10.6 150 
Munch and Basset 
[161] 
500-1000 SPE GC-CI-MS-MS 0.20-0.66 150 
Charrios et al. [148] 500 SPE GC-CI-MS 0.70-1.30 200 
Hung et al. [159] 4.5 SPME GC-CI-MS-MS 3.2-15.2 100
a
 
Ripolles et al. [162] 500 SPE 
HPLC-CI-MS-
MS 
1.0-8.0 100 
Cheng et al. [163] 500 SPE GC-CI-MS-MS 0.78-1.78 156 
 500 CSPE GC-CI-MS-MS 0.33-1.36 126 
 100 MLLE GC-CI-MS-MS 1.80-3.90 94 
Grebel et al. [158] 40 SPME GC-NPD 1-890 75 
 40 SPME GC-CI-MS 30-138 75 
  40 SPME GC-NCD 57-193 75 
Wang et al. [164] 0.1 LLE GC-EI-MS 32-100.6 90 
Current method                                  10 ICECLES GC-EI-MS 0.2 200
a
 
a
Methods with utilizing automated sample preparation 
LOD = limit of detection; SPE = solid-phase extraction; SPME = solid-phase 
microextraction; CSPE = cartridge solid-phase extraction; MLLE = microliquid liquid 
extraction; ICECLES = ice concentration linked with extractive stirrer; HPLC = high-
performance liquid chromatography; MS = mass spectrometry; ESI = electrospray 
ionization; GC = gas chromatography; CI = chemical ionization; HR = high resolution; NPD 
= nitrogen phosphorous detector; NCD = nitrogen chemiluminesence detector; EI = electron 
ionization. 
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1.10.  Ideal Analytical Method /Technique For Analysis of Nitrosoamines 
 Because of the challenges associated with current methods for analysis of 
NAs, it is very important to devise a method that may allow analysis of NAs at the 
desired sensitivity from small sample volumes and more widely available analytical 
instrumentation, such as low resolution GC-MS. In addition, the ideal analytical 
method should be simpler, “greener’, and must have ‘automated’ sample preparation 
protocols that should have a stark contrast to some of the sample preparation 
techniques listed in Table 1.5 (i.e., SPE, MLLE, and LLE). ICE Concentration Linked 
with Extractive Stirrer (ICECLES), a sample preparation protocol developed by 
Maslamani et al. [165] qualifies for most of the criteria listed above. Chapter 3 details 
the use of ICECLES-GC-EI-MS for the analysis of NDPA.  
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CHAPTER 2. DETERMINATION OF FREE CYANOCOBINAMIDE BY 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS 
SPECTROMETRY 
 
2.1. Abstract 
In recent years, Cobinamide (Cbi) has shown promise as a therapeutic for 
cyanide poisoning.  There are several forms of Cbi based on the identity of the ligands 
bound to the cobalt in Cbi and these different forms of Cbi have divergent behavior 
(e.g, the aquo and hydroxo forms of Cbi readily bind to proteins, limiting their 
distribution significantly, whereas [Cbi(CN)2] does not). While current analysis 
techniques only measure total Cbi, methods to elucidate the behavior of ‘available’ 
Cbi versus cyanide-complexed Cbi would be valuable for biomedical and 
pharmacokinetic studies. Therefore, a method was developed for the analysis of 
cyanide-complexed Cbi in plasma via liquid chromatography tandem mass 
spectrometry (LC-MS-MS). Plasma samples were prepared by denaturing proteins 
with 10% ammonium hydroxide in acetonitrile. The resulting mixture was 
centrifuged, and the supernatant was removed, dried, and reconstituted. Cyanide-
complexed Cbi was then analyzed via LC-MS-MS. The limit of detection was 0.2 
µM, and the linear range was between 1-200 µM. The accuracy was 100±17% and the 
precision, measured by relative standard deviation (%RSD), was ≤18.5%. Carryover, 
a severe problem when analyzing Cbi via liquid chromatography was eliminated 
using a polymeric-based stationary phase (PLRP-S) and a controlled washing 
protocol. The method allowed evaluation of the cyanide-bound and ‘available’ Cbi 
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from treated animals and, when paired with a method for total Cbi analysis, allows for 
estimation of Cbi utilization when treating cyanide poisoning. 
 
2.2. Introduction  
Current treatments for cyanide exposure (CN
-
 and HCN, inclusively 
represented as CN) include three general classes of agents: methemoglobin generators 
(sodium nitrite, amyl nitrite, and dimethyl aminophenol), sulfur donors (sodium 
thiosulfate and glutathione), and direct binding agents (hydroxocobalamin and 
dicobalt edetate) [92]. While each type of treatment has been effective at countering 
the toxic effects of cyanide, each has major limitations, especially during mass 
casualty situations. For example, all cyanide approved antidotes require intravenous 
administration [91].  
Methemoglobin generators oxidize hemoglobin in the red-blood cells to 
produce methemoglobin [166], a complex with high affinity for cyanide [105]. 
However, production of methhemoglobin leads to methemoglobinemia, which 
reduces oxygen transport in the erythrocytes and tissues [60, 91, 167, 168]. This is 
especially dangerous when smoke inhalation has occurred, causing concurrent 
carboxyhemoglobinemia and methemoglobinemia [92]. Nitrites, such as sodium 
nitrite, are also known to cause severe hypotension, cardiovascular instability and 
hypoxia [60]. Nitrites can also cause oxidative stress on fetal hemoglobin in pregnant 
patients [39]. It has been proposed recently that nitric oxide generated from nitrites 
displaces cyanide bound to the active site of cytochrome c oxidase [84, 95-97], 
restoring the activity of cytochrome c oxidase. The displaced CN may then be 
scavenged by circulating MetHgb, or converted to SCN
-
 in the presence of sulfur 
donors [84].  Sulfur-donor antidotes detoxify cyanide by converting cyanide to 
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thiocyanate with the help of sulfurtransferase enzymes (e.g., rhodanese and 3-
mercaptopyruvate sulfurtransferase) [169]. However, sulfur donors are limited due to 
variable subcellular distribution of sulfurtransferase enzymes [169]. For example, 
rhodanese is concentrated in the mitochondrial matrix of the liver and kidney, but is 
not prevalent in the central nervous system [92]. Thiosulfate, the only U.S. FDA-
approved sulfur donor cyanide antidote, also has a disadvantage of slow uptake into 
cells. Large concentrations of sodium thiosulfate produce side effects such as nausea, 
vomiting, local skin and muscle pain at the site of infusion, headache, and 
disorientation [60]. Recently, other sulfur donor compounds, including 3-
mercaptopyruvate (3MP) [92, 105, 115, 170] and dimethyl trisulfide [97, 112, 114, 
171, 172] have been suggested as more efficient sulfur donors for cyanide therapy. 
While these novel sulfur donors have many advantages, they are still under 
development.  Direct binding agents offer an alternate mechanism for detoxifying CN 
by sequestering cyanide from cytochrome c oxidase to effectively reduce the toxicity 
of cyanide. One such binding agent is hydroxocobalamin (Cbl), which more strongly 
binds cyanide than cytochrome c oxidase [39]. Cbl is the only U.S. FDA-approved 
binding agent [39, 173] and is relatively safe and effective [92], but binds only one 
cyanide ion per molecule, and has a very high molecular weight. Therefore, it requires 
large doses (i.e., approximately 4 to 5 g) and intravenous administration to be 
effective, limiting its use in mass casualty situations [92, 115].  Cobinamide (Cbi), the 
penultimate precursor in the hydroxocobalamin biosynthetic pathway [92, 174], has 
been suggested as an effective cyanide binding agent. To date, studies have shown 
that Cbi is superior to current FDA-approved treatments, mainly due to its flexible 
administration (typically intramuscular) and therapeutic index advantages [30, 93]. 
The greater effectiveness of Cbi is due to its extremely high affinity for cyanide (KF, 
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overall = 10
22
 M
-1
) [30, 115, 174], its ability to directly bind two cyanide ions, and its 
relatively high solubility [115, 174]. Depending on the pH and ligands present, 
cobinamide can exist in several forms, such as diaquocobinamide [Cbi(H2O)2]
2+
, 
hydroxoaquocobinamide [Cbi(OH)(H2O)]
+
, and dihydroxocobinamide [Cbi(OH)2], 
[120]. Cobinamide itself exists predominantly as [Cbi(OH)(H2O)]
+
 at neutral pH, as 
[Cbi(H2O)2]
2+
 under acidic conditions (Pka=5.9), and as [Cbi(OH)2] under basic 
conditions [175]. In the presence of cyanide, either one or both of the aquo or hydroxo 
ligand(s) are replaced to produce [Cbi(CN)(H2O)]
+
, [Cbi(CN)(OH)], or [Cbi(CN)2] 
[120, 175] depending on pH, the CN concentration, and the reaction time. Of course, 
a variety of other ligands may bind to the Cbi, depending on its environment. 
The multiple species of Cbi exhibit disparate kinetic, thermodynamic, and 
biological behavior. For example, the aquo and hydroxo forms of Cbi significantly 
bind to transcobalamin protein (TC), haptocorrin (HC), and intrinsic factors (IF), 
while the dicyano form of Cbi does not. This likely results in substantially different 
distribution of these species [176-178]. Several methods have been developed for the 
determination of total Cbi by conversion to [Cbi(CN2)]
0
 utilizing a large excess of 
CN. These methods include electrochemical, spectrophotometric, and 
chromatographic techniques [6, 79, 115, 120, 174]. Although these methods perform 
well for the analysis of total Cbi, they lack the ability to measure ‘available’ and 
cyanide-bound Cbi. For example, we developed a method for the simultaneous 
analysis of total Cbi and 3-mercaptopyruvate in swine plasma [6], while a different 
group reported a method for the analysis of total Cbi alone, also in swine plasma 
[179]. While these methods give valuable information as to the distribution and 
kinetics of the Cbi species in aggregate, they fail to elucidate the interplay between 
Cbi species and the contribution of these species to the effectiveness of Cbi. This 
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information is necessary for gaining a complete understanding of the distribution and 
pharmacokinetic profile of Cbi. Therefore, the development of a selective method for 
the analysis of individual Cbi species is desired. Most importantly, the selective 
analysis of cyanoCbi species (i.e., cyanoCbi is defined as Cbi bound to at least one 
CN
-
 ion) would allow determination of the pharmacokinetic behavior of cyanide-
bound Cbi.  In combination with the determination of the total Cbi, factors 
contributing to the efficacy of Cbi may be revealed. Such information may help in the 
identification of more effective formulations of Cbi for treatment of cyanide. 
The objective of this project was to develop a single analytical method for the 
determination of plasma concentrations of cyanoCbi species, (i.e., [Cbi(CN)2] and 
[Cbi(CN)Y]
z
, with Y representing a ligand bound to the Cbi and z representing the 
formal charge of the complex). A secondary objective was to significantly reduce or 
eliminate the well-known problem of severe carryover of Cbi during liquid 
chromatography analysis [118]. 
1.10. 2.3. Experimental 
2.3.1. Reagents and standards  
All reagents were HPLC grade, unless otherwise noted. Sodium cyanide 
(NaCN), potassium cyanide (KCN), urea, ammonium sulfate, acetonitrile, zinc 
chloride, zinc acetate, sodium hydroxide, perchloric acid, and ammonium hydroxide 
were all obtained from Fisher Scientific (Hanover Park, IL, USA). Millex® 
tetraflouropolyethylene syringe filters (0.22 µm, 4 mm, Billerica, MA, USA) were 
also purchased from Fisher Scientific. Sodium dodecylsulfate, potassium hydroxide, 
potassium chloride, p-toluenesulfonic acid monohydrate, and urea, were supplied by 
Sigma-Aldrich (St. Louis, MO, USA). Formic acid was obtained from Thermo 
Scientific (Rockford, IL, USA). Water was purified to 18 mΩ-cm using a Water PRO 
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PS system (Labconco, Kansas City, KS, USA). Aquohydroxo-cobinamide was 
obtained from Dr. Gerry Boss, MD, Department of Medicine, University of 
California-San Diego, La Jolla, USA [6, 116]. A stock solution of 20 mM 
aquohydroxo-cobinamide was prepared by diluting the aquohydroxoCbi with de-
ionized water and storing at 4°C in amber vials.  
Calibration and quality control (QC) standards of dicyanoCbi were prepared 
by adding 1 mole of aquohydroxo-cobinamide to 2 molar equivalents of NaCN 
(dissolved in 10 mM sodium hydroxide), allowed to stand for 5 minutes, serially 
diluting to the desired concentration, and spiking into plasma in a 9:1 volume ratio. 
Spiked standards were mixed thoroughly and allowed to stand for 10 minutes prior to 
sample preparation to ensure homogeneity. 
Caution. Cyanide is toxic and hazardous to humans at blood concentrations of 
∼20 μM or higher. HCN is produced from aqueous cyanide containing solutions near 
or below a pH of 9.2. Therefore, all aqueous cyanide standards were prepared in 10 
mM NaOH and handled in a well-ventilated hood with cyanide waste appropriately 
labeled. Cyanide-containing waste was appropriately disposed via approved processes 
at the institution where it was generated.  
2.3.2. Biological fluids 
Swine plasma (heparin anti-coagulated) and rabbit plasma (EDTA anti-
coagulant) used for method development and validation were purchased from Pel-
freeze Biological (Rogers, AR, USA), and kept frozen at -80°C until used.  Plasma 
from rabbits exposed to cyanide and treated with 1H-tetrazole-5-acetylcobinamide 
was obtained from the University of California-Irvine (Beckman Laser Institute). New 
Zealand male rabbits (315 to 320 g, N = 3) were anesthetized with an initial 
intramuscular injection of Ketamine HCl 50 mg/kg (Ketaject, Phoenix Pharmaceutical 
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Inc., St. Joseph, MI) and Xylazine 5 mg/kg (Anased, Lloyed Laboratories, 
Shenandoah, IA). After administration of anesthesia, a catheter was placed in the 
animal’s marginal ear vein to administer continuous intravenous anesthesia with 
Ketamine/Xylazine at 0.17 mL/min during central line placement. The rate of 
anesthesia delivery was subsequently increased to 0.19 mL/min for the duration of the 
experiment. Rabbits were ventilated at 100% O2 at 18 respirations per minute. Blood 
samples were drawn prior to CN exposure to establish a baseline. NaCN (20 mg in 60 
mL 0.9% NaCl) was administered intravenously at 1 mL/min. Blood samples were 
drawn at 15 and 25 mins post-NaCN infusion start. After 30 mins of CN infusion, the 
ventilator rate was reduced to 16 respirations per minute, and room air was used for 
ventilation. Blood samples were subsequently drawn at 35 min of NaCN infusion and 
until blood pressure reached a target value of 40-58 mm Hg systolic. At this trigger 
point (designated as “time 0”), the antidote, 1H-tetrazole-5-acetylcobinamide (1 
mL of 150 mM Cbi), was injected intramuscularly into the left front leg muscle. 
Starting at 5 minutes post-antidote administration, blood was drawn into K2-EDTA 
vacutainers (BD, Franklin Lakes, NJ) at 2.5, 5, 7.5, 10, 15, 30, 45, 60, and 90 minutes 
(i.e., the post-antidote samples). The plasma was then immediately separated from 
blood by centrifugation at 4 °C for 20 min. The plasma was transferred to a clean 
microcentrifuge tube, flash-frozen in liquid nitrogen, and shipped overnight on dry ice 
to South Dakota State University for analysis. Upon receipt, the plasma was stored at 
-80 °C until analysis was performed. All rabbits were cared for in compliance with the 
“Principles of Laboratory Animal Care’’ formulated by National Society for Medical 
Research and the “Guide for the Care and Use of Laboratory Animals” prepared by 
the National Institutes of Health [6, 180].  The animal study was approved by the 
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University of California-Irvine Institutional Animal Care and Use Committee 
(IACUC). 
2.3.3. Sample preparation of Cbi species 
Plasma samples were denatured by adding 700 µL of 10% ammonium 
hydroxide in acetonitrile to 100 µL plasma. The samples were then vortexed briefly 
(~10 seconds), and centrifuged at 16,500 x g for 20 minutes at 8 °C. The supernatant 
(650 µL) was collected into a 2-mL centrifuge vial and further centrifuged for an 
additional 10 minutes under the same conditions. Afterwards, the supernatant (600 
µL) was transferred into a 4-mL glass vial and dried with N2. The samples were then 
reconstituted in 10% acetonitrile, filtered with a 0.22 µm tetraflouropolyethylene 
syringe filter, and analyzed. Other denaturing agents were tested, including potassium 
chloride (1 g/mL), zinc chloride (1 g/mL), zinc acetate (1 g/mL), ammonium sulfate 
(1 g/mL), p-toluenesulfonic acid monohydrate (1 mM), and sodium dodecylsulfate 
[181]. Combinations of denaturing agents were also evaluated, including zinc chloride 
and urea (1 g/mL each), zinc actetate and urea (1 g/mL each), and perchloric acid (4 
mM):potassium hydroxide (1 M) [181]. However, these agents produced inadequate 
recovery of cyanoCbi.  
For total Cbi analysis, we used our previously published method [6]. Briefly, a 
100 µL cyanide solution (10-mM KCN in 0.1 M NaOH) was added to 50-µL plasma 
and heated on a heat block at 80 °C for 15 min. Then, acetone (600 µL) was added to 
precipitate the proteins, followed by centrifugation, transfer of the supernatant, drying 
under N2, reconstitution in 5 mM aqueous ammonium formate with 10% methanol, 
and filtering prior to LC-MS-MS analysis. 
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2.3.4. Initial MS-MS-Analysis 
All mass spectrometric analysis was performed by an AB Sciex QTRAP 5500 
MS (AB Sciex, Framingham, MA, USA) with electrospray ionization in positive 
mode. Mass spectra were initially acquired by direct infusion of aqueous Cbi 
solutions (10 µL/min) with scans of MS1 from 200-1200 Da over 1.6 minutes. The 
entrance orifice potential was 180 V, and the collision cell exit potential was 11 V. 
The curtain gas and ion source gases were operated at 30 and 40 psi, respectively. The 
ion spray voltage was 5500 V with a temperature of 500 K, and the collision 
activation dissociation (CAD) was set to “high”. The low energy collision-induced 
dissociation tandem mass spectrometric analysis (CID-MS-MS) was conducted with a 
linear accelerator (LINAC) collision cell of the triple quadrupole/linear ion trap 
instrument. The CID-MS-MS was performed in multiple-reaction monitoring (MRM) 
mode with optimum MRM parameters shown in Table 2.1. Analysis and data 
acquisition was accomplished using Analyst software (Applied Biosystems, Version 
1.6.3). The transitions (m/z) monitored for cyanoCbi were 1015.5 → 930.8 and 
1015.5 → 988.5. We have seen in the past, and also in the current study, that the 
1064.9 m/z transitions (i.e., dicyanoCbi with sodium) produce poor sensitivity, with 
lower limits of detection, as compared to the 1015 transitions [6]. Consequently, the 
1015.5 transitions were used for quantification and, when present above baseline 
noise, the 1064.9 transitions monitored for identification of dicyanoCbi. 
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Table 2. 1. Optimized MS-MS MRM parameters for cyanoCbi species. 
Compound
a
 MS1 (m/z Da)
b
 MS3 (m/z Da)
c
 DP (V)
d
 CE (V)
e
 CXP
f
 (V) 
[Cbi(CN)2Na] 1064.9 930.8 (ID)
g
 263.11 97.47 11 
[Cbi (CN)Y]
z
 1015.5 930.8 (Quant)
h
 249.42 75.91 11 
[Cbi (CN)Y]
z
 1015.5 988.5 (ID)
g
 237.79 50.71 11 
a
Y represents a ligand bound to the Cbi and z represents the formal charge of the complex 
b
Precursor ion   
c
Product ion   
d
Declustering potential 
e
Collison energy
   f
Collision cell exit potential 
g 
Identification ion 
(dicyanoCbi)          
h
Quantification ion (cyanoCbi)
   
 
 
 
 
2.3.5. HPLC-MS-MS Analysis 
Liquid chromatography-tandem mass spectrometry (LC-MS-MS) was 
conducted on a Shimadzu High Performance-LC system (HPLC, LC-20AD, 
Shimadzu Corp., Kyoto, Japan) coupled with the QTRAP described above. Samples 
were separated by a polymeric reversed phased column, PLRP-S (300A, 50 x 2.10 
mm x 3 micron) from Agilent Technologies (Santa Clara, California, USA). An 
isocratic method of 100% acetonitrile over 5 minutes was used. The optimized 
transitions (Table 2.1) were monitored.  
Carryover is a major and well-known problem when analyzing Cbi species 
[118]. Cbi can bind both column and LC-MS-MS components (e.g. the autosampler 
syringe). In order to reduce day-to-day carryover of Cbi, a PLRP-S stationary phase 
was used to avoid the strong interaction of Cbi with free silanols present in typical 
reversed-phase stationary phases. Moreover, a cleaning protocol was devised to 
eliminate residual Cbi in the LC-MS-MS components. The cleaning procedure was 
based on addition of anions with high affinity for Cbi to the LC components and the 
column to release bound Cbi as cyanide- or sulfite-complexed Cbi. The cleaning 
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procedure consisted of 3 steps: 1) rinsing the LC instrumentation (minus column) via 
injections of aqueous cyanide, 2) rinsing the column with sulfite-containing mobile 
phase, and 3) injecting aqueous NaCN (in basic solution) into the complete LC-MS-
MS system and monitoring the detection of cyanoCbi. The flow chart in Figure 2.1 
schematically represents the cleaning protocol for both the HPLC-MS-MS system and 
the column. Following analysis of multiple Cbi samples (e.g., analysis of calibration 
standards and samples from a model of treatment for cyanide exposure), the column 
was removed from the LC-MS-MS. The LC autosampler and connections without 
column were rinsed (0.25 mL/min) with water, 5% and 10% acetonitrile (ACN) for 
15, 10, and 20 min, respectively, to unbound or weekly-bound residual sample 
components into waste using the diverter valve on the MS. The mobile phase was 
then changed to 100% ACN. Subsequently, injections (50 times) of aqueous cyanide 
(100 µM CN in 10 mM NaOH) were performed to bind residual Cbi and allow its 
release, as cyanoCbi, into the waste. On the last injection, the cyanoCbi signal was 
evaluated to determine if residual Cbi was still present in the LC system (minus 
column). If cyanoCbi was present, the injections of cyanide were repeated as 
described above and the final injection was evaluated. This process was repeated until 
no cyanoCbi was present in the eluant. Subsequently, 5 and 10% aqueous ACN 
solutions (at 0.5 mL/min) were used to flush the system of NaCN and NaOH. The 
column was separately washed on a different HPLC using an aqueous solution of 
sodium sulfite and ACN (1:10 of 1 mM Na2SO3:ACN) at 0.1 mL/min (i.e., sulfite 
strongly binds to Cbi, although not strongly as CN). After this, a 5%-ACN solution (4 
hr) followed by 10% ACN (2 hr) were used to wash residual salt from the column at 
0.05 mL/min. The column was then equilibrated to 100% ACN, and further cleaned 
by performing at least 70 autosampler injections of 100 µM cyanide in 10 mM NaOH 
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(40 µL each). The column was then equilibrated with 100% ACN and stored for 
future use.  Prior to sample analysis, the PLRP-S column was installed on the LC-MS-
MS system and 100 µM cyanide in 10 mM NaOH was analyzed by the cyanoCbi 
method presented here to verify that residual Cbi was eliminated from the LC-MS-MS 
system (i.e., cyanide strongly binds to Cbi to release any residual Cbi in the 
autosampler or column which would appear as cyanoCbi during the LC-MS-MS 
analysis). The absence of a cyanoCbi peak confirmed the instrument and the column 
were free from residual Cbi (i.e., residual Cbi appears as a cyanoCbi peak in the 
chromatogram). In our work, if a cyanoCbi was detected, following the procedure in 
Figure 2.1, the signal was very small and repeated injections of 100 µM CN (≤10) 
eliminated the residual Cbi. Although we did not observe a large residual cyanoCbi 
peak following the procedure in Figure 2.1, if a large cyanoCbi is signal is present, the 
overall cleaning procedure may need to be repeated multiple times to eliminate 
residual Cbi from the LC-MS-MS components. 
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 Figure 2. 1. Flow chart for cleaning protocol for the LC-MS-MS. ACN = 
acetonitrile. 
 
 
 
52 
 
 
 
2.3.6. Method Validation 
FDA guidelines [182-186] were followed for bioanalytical method validation. 
For the determination of the limit of detection (LOD), multiple concentrations of 
dicyanoCbi (i.e., 100, 200, and 500 nM) were spiked in plasma, and analyzed by the 
method. The LOD was defined as the concentration that reproducibly produced a 
signal to noise ratio of 3, with the noise calculated as the peak-to-peak noise of the 
blank (i.e., non-spiked plasma) over the retention time of cyanoCbi. The linear range 
was determined by analyzing dicyanoCbi calibration standards in plasma (each in 
triplicate) at nine different concentrations ranging from 0.5 to 200 µM (i.e., 0.5, 1, 2, 
5, 10, 20, 50, 100, and 200 µM). The criteria used for the lower limit of quantification 
(LLOQ) and upper limit of quantification (ULOQ) were as follows: (1) calibrator 
precision (measured as percent relative standard deviation, %RSD) of ≤20% and (2) 
an accuracy of 100±20% of the nominal calibrator concentration back-calculated from 
the calibration curve. The cyanoCbi concentration was back-calculated from the 
calibration equation using the signal of each calibrator and then averaged. Inter- and 
intra-assay precision and accuracy were determined by analyzing low (3.5 µM), 
medium (35 µM) and high (150 µM) quality control (QC) standards in quintuplicate. 
These QCs were not included in the calibration curve. DicyanoCbi calibration curves 
were prepared each day of analysis.  
For stability studies, QCs (low and high) were stored at various temperatures 
and analyzed at multiple storage times. The short-term stability includes autosampler 
stability (i.e., prepared QCs stored in the autosampler at 15 °C) and bench top stability 
(i.e., prepared QCs stored on the bench top at room temperature (RT)). For both 
autosampler and bench top stability, QCs were analyzed immediately and after 2, 4, 8, 
12, and 24 hours. Stability for each experiment was measured as a percentage of the 
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original QC signal (i.e., the QC analyzed immediately), with samples considered 
stable if the stored sample produced 100±20% of the original signal.  
The recovery was evaluated by comparing QCs (low, medium and high) 
prepared in plasma to equivalent concentrations of QCs prepared in aqueous solution. 
The plasma samples were prepared using the sample preparation procedure described 
above, but the aqueous samples did not go through the sample preparation, except that 
they were dried, and reconstituted in 10% aqueous ACN. The standards were prepared 
in quintuplicate, and the recovery was calculated as a percentage of the average signal 
in plasma compared to the aqueous standards. Matrix effects were evaluated by 
comparison of the slope of an aqueous calibration curve to that of plasma. A matrix 
effect was said to be present if the slope of the calibration curve in water samples was 
significantly different from that in plasma samples. 
1.11. 2.4. Results and Discussion 
2.4.1. Sample Preparation and Analysis of cyanoCbi 
In previous work, Cbi has been measured as total Cbi by adding excess 
cyanide to convert all Cbi species to dicyanoCbi [6, 118, 120, 127]. In this study, 10% 
ammonium hydroxide in ACN, as a denaturating solution, coupled with two-step 
centrifugation allowed extraction of cyanoCbi species, as opposed to total Cbi. It is 
important to note that other chaotropic and kosmotropic agents were tested (results 
not shown), but the ammonium hydroxide/acetonitrile combination was the only one 
which produced acceptable recoveries of cyanoCbi. The ammonium hydroxide was 
used to disrupt ionic interactions, likely disrupting salt bridges formed between the 
cobalt in the cobinamide and negatively charged moieties in the plasma protein 
structure. The ACN lowers the dielectric constant of the resulting solution to 
precipitate plasma proteins and simultaneously disrupts hydrophobic and hydrogen 
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bond interactions in the protein. The combination of these two denaturing agents 
produced acceptable recoveries of cyanoCbi for analysis. We observed that any 
further increase in the percentage of ammonium hydroxide concentration and/or 
increase in the contact time during the deproteinization process produced a decrease 
in the recovery of cyanoCbi. This was likely caused by a shift in the equilibrium or 
kinetic stability of the Cbi species, resulting from increased hydroxo forms of Cbi 
with increased pH. After denaturing the proteins, the sample was centrifuged, and the 
supernatant was dried and reconstituted for analysis. The sample preparation for the 
method presented here is relatively simple and easy, and the chromatographic method 
is shorter as compared to other methods [6, 118].  Moreover, the stationary phase 
chosen for this method is much less likely to bind Cbi under the chromatographic 
conditions used. Figure 2.2 shows the chromatogram of cyanoCbi (eluted at 0.85 
minutes) analyzed from spiked swine plasma. The chromatographic peak shape 
(As=1.3) and resolution were excellent (i.e., there were no other significant present in 
the chromatogram). The chromatographic run was 5 minutes in total. In future work, 
we will evaluate the necessity of the relatively long equilibration time following 
elution of cyanoCbi (i.e., the method is isocratic, allowing for no equilibration time 
between runs, and cyanoCbi elutes within the first minute).  
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Figure 2. 2. LC-MS-MS chromatograms of dicyanoCbi-spiked and non-spiked swine 
plasma. CyanoCbi elutes at 0.85 min. The extra 4 minutes (after the elution of the 
analyte) allowed for enough equilibration and possible elimination of some of the 
residual Cbi in the system.  
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Figure 2. 3.  Peaks obtained after injection of 100 µM NaCN )in 10 mM NaOH) 
following one validation analysis (i.e., approximately 42 dicyanoCbi-spiked swine 
plasma samples were analyzed), but before performing the cleaning protocol (Figure 
1). Chromatograms with the column (cyanoCbi eluted at 0.85 min) and after removing 
the column (cyanoCbi eluted at 0.25 min) are shown. The presence of cyanoCbi 
without the column shows that Cbi is bound to extra-column components of the LC-
MS-MS system. The increased signal of cyanoCbi with the column attached indicates 
that some residual Cbi is also associated with the column. The inset presents the 
analysis of cyanoCbi (via injection of 100 µM CN) following the cleaning protocol, 
showing undetectable Cbi, which demonstrations the excellent performance of the 
protocol to eliminate carryover. 
  
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
0 1 2 3 4 5
A
b
u
n
d
a
n
ce
 (
x
1
0
6
) 
Time (min) 
CyanoCbi with 
column 
CyanoCbi 
no column 
0
5
10
15
20
25
30
35
40
45
0 1 2 3 4 5
A
b
u
n
d
a
n
ce
  
Time (min) 
57 
 
 
Cbi has an extremely high affinity for oxide surfaces. Therefore, common 
reversed-phase chromatography stationary phases, which have a silica-based solid 
support (e.g., C18), are poor choices for Cbi analysis, even though multiple methods have 
been published using this approach [6, 118], including one from our group. In fact, the 
challenges associated with residual Cbi were vividly reported by McCracken and Brittain, 
who used a reversed-phase C18 column (i.e., Phenomenex Kinetex C18 column) [118]. 
The PLRP-S stationary phase and the acetonitrile mobile phase used in this study 
minimized carryover that has plagued Cbi analysis. Although carryover was greatly 
decreased when using the PLRP-S column, carryover was still evident in the method 
presented in this study (Figure 2.3). This is likely caused by sorption of Cbi to a number 
of high affinity sites in the autosampler, LC connections and the column. Therefore, we 
devised a wash protocol to remove residual Cbi from the column and LC components 
(Figure 2.1). To evaluate the extent of residual Cbi, an aqueous cyanide solution (100 µM 
in 10 mM NaOH) was injected via the autosampler (40 µL) and analyzed via the method 
presented here. Cyanide has a high affinity for Cbi, releasing bound Cbi from the LC-
MS-MS system as cyanoCbi, allowing its detection via the tandem mass spectrometry. 
Therefore, if bound Cbi is present in the LC-MS-MS, a cyanoCbi peak will be present in 
the chromatogram following injection of cyanide. Figure 2.3 shows the residual Cbi 
detected in the complete LC-MS-MS system, when the column is attached (elution at 
0.85 minutes), and the LC-MS-MS system with the column removed (elution at 0.25 
minutes) immediately after a full-day validation experiment (i.e., approximately 42 Cbi 
containing samples ranging from 0.5 to 200 µM). It is evident that Cbi does bind to both 
column and the other components of the LC-MS-MS system with approximately one-
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third of the cyanoCbi signal remaining after removal of the PLRP-S column. However, 
with the polymeric stationary phase coupled with the cleaning procedure devised, 
residual Cbi was eliminated, as clearly shown in the Figure 2.3 inset, where a 
chromatogram of cyanoCbi (i.e., injection of 100 µM NaCN in 10 mM NaOH) after 
using the cleaning protocol shows cyanoCbi was not detected. 
2.4.2. Limit of detection, sensitivity and linear range  
The LOD of cyanoCbi from plasma was 200 nM, which is the same as that 
obtained in our previous total Cbi method (200 nM) [6]. It is likely that the LOD was the 
same for the current method, even though only cyanoCbi was measured, because binding 
of Cbi to the column was minimized.  
The LLOQ and ULOQ were 1 and 200 µM, respectively. This represents over two 
orders of magnitude for the linear range (LR). It should be noted that 200 µM was the 
highest concentration tested, therefore, the ULOQ for the method may be higher than 200 
µM. The LR is much improved from our previous work [6] and that which was reported 
by Boss et al. [187]. This, again, is likely because the interaction of Cbi with the 
chromatographic stationary phase was minimized. The LR of this method is well-suited 
for translational studies, including pharmacokinetic analysis of cyanoCbi [6]. The 
regression equations, correlation coefficients (R
2
), and the Percent Residual Accuracies 
(PRAs) [188] for the 3-day validation study are outlined in Table 2.2. The PRA values 
for all the calibration curves generated for the 3-day validation process was ≥90% (Table 
2.2), indicating a good fit over the entire linear range [188]. In addition, the precision and 
the accuracy of the calibration curves were acceptable (Table 2.3) [182-184, 186]. The 
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day-to-day inconsistency in the slope and intercept over the 3-day validation study 
require that a calibration curve be prepared for each day of analysis.   
 
Table 2. 2. Regression models, R
2
 and PRA values for calibration curves over a 3-day 
period. 
Day Calibration Equation
a
 R
2
 PRA
b
 
1 y = 81397x-29620 0.9842 90.2 
2 y = 42027x-18780 0.9872 90.2 
3 y = 163762x-95040 0.9914 92.2 
a
Equation in the form of y = mx + b, where x = cyanoCbi concentration 
(µM) and y = the peak area abundance of the 1015→930 m/z transition 
from the LC-MS-MS chromatogram.  
b
Percent Residual Accuracy [188].  
 
2.4.3. Accuracy and precision  
 The intra- and interassay accuracy and precision were determined by analyzing 
low, medium and high QCs in quintuplicate over three different days, with the results 
summarized in Table 2.3. The intraassay precision for the cyanoCbi species in swine 
plasma was <18.5% RSD, while the accuracy was 100±18%. The interassay accuracy and 
precision were 100±17% and <16% RSD, respectively. Even though the precision and 
accuracy are slightly worse as compared to the total cobinamide methods presented by 
Ma et al. [117], Stutelberg et al. [6], and McCracken and Brittain [118], the overall 
precision and accuracy for this method were acceptable [182-184]. The accuracy and 
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precision are likely worse for the current method because of the increased variability in 
the recovery of cyanoCbi using the 10% ammonium hydroxide versus a large excess of 
cyanide to measure the total Cbi [6, 118, 127].  
 
Table 2. 3. Intra- and interassay accuracy and precision for the analysis of dicyanoCbi-
spiked swine plasma. 
Nominal 
Intraassay Intraassay Interassay Interassay 
Conc. (µM) 
Accuracy
a
 (%) Precision
a
 (%) Accuracy
b
 (%) Precision
b
 (%) 
3.5 100±14 <18.5 100±14 <16 
35 100±17 <12.5 100±17 <11 
150 100±16 <6.5 100±8 <9 
a
QC method validation for Day1 (N=5)    
b
Average of QCs for the 3 different days of 
validation (N=15) 
 
2.4.4. Stability, recovery and matrix effects 
In order to reduce the high variance associated with residual Cbi from run-to-run 
for the stability studies, the short-term stability studies were carried out for the low QC 
first, followed by the high QC on separate days. The benchtop and autosampler (15°C) 
stability fell within 100±14% over 24 hours. The analyte was stable for at least 30 days in 
a standard refrigerator at 4 °C. As shown in Table 2.4, these results are consistent with 
what was reported earlier [6, 118]. 
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Table 2. 4. Stability profile for total Cbi for current and previous studies. 
Stability expt. Ref.  Total Cbi stability 
Long-term [6]  ≥30 days for 1.5 and 35 µM at 4, -30, and -80 °C 
 
[118] 
 ≥60 days for 0.072 and 7.2 µM (reported as 75 and 7500 
ng/mL) at -70 °C  
 CS
a
  ≥30 days for 3.5 and 150 µM at 4 ºC 
 
 
 
Bench-top  [6]  ≥24 hours for 1.5 and 35 µM at RT 
 CS
a
  ≥24 hours for 3.5 and 150 µM at RT 
 
 
 
Freeze-thaw  [6]  3 cycles; freezer at -80 °C 
 [118]  3 cycles; freezer at -70 °C 
 
 
 
Autosampler  [6]  ≥24 hours for 1.5 and 3.5 µM at 15 °C  
 
[118] 
 ≥4 days for 0.072 and 7.2 µM (reported as 75 and 7500 
ng/mL) at 2-8 °C  
  CS
a
  ≥24 hours for 3.5 and 150 µM at 15 °C  
a
Current study     
 
The matrix effect was evaluated by comparing the slopes from the calibration 
curves of the analyte in an aqueous matrix to that of plasma. The slope of the calibration 
curve in the plasma matrix was 0.4 times that of the aqueous matrix calibration curve, 
which indicates a considerable matrix effect. The matrix effect produced in this study is 
similar to what we reported previously for total Cbi analysis [6]. The recoveries of 
cyanoCbi for the low, medium and high QCs were 20, 40, and 50%, respectively. 
Stutelberg et al. [6] reported recoveries of total Cbi of 29% (for the low QC), 29% 
(medium QC) and 33% (high QC), while McCracken and Brittain reported 56%, 59%, 
and 62% for the low, medium, and high QCs, respectively [118]. The increased 
variability of the recovered Cbi compared to other studies is likely due to increased 
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variability when extracting cyanoCbi with 10% ammonium hydroxide as compared to 
analysis of total cyanide using excess cyanide. Since the matrix effect is a component of 
the signal recovery, the matrix effect is responsible for most of the signal loss seen, 
except for the low QC. 
2.4.5. Analysis of Free CyanoCbi in Exposed Animals 
The validated method was applied to analyze free cyanoCbi from the plasma of 
1H-tetrazole-5-acetylcobinamide (Cbi)-treated rabbits. Representative chromatograms of 
rabbit plasma obtained prior to cyanide exposure and plasma from the same rabbit 
following cyanide exposure and Cbi treatment (10-min post-treatment) are shown in 
Figure 2.4. Analogous to Figure 2.2, the cyanoCbi peaks were sharp and symmetrical. 
Moreover, the method was extremely selective, with no interfering peaks present in the 
pre-exposed rabbit plasma over the entirety of the chromatogram.  
The cyanoCbi concentration, following IM-Cbi treatment of cyanide-exposed 
rabbits, is plotted in Figure 2.5. The cyanoCbi concentration is around 1 µM at 2.5 min 
following IM Cbi administration and increases to about 35 µM by 60 min. This 
progressive increase in cyanoCbi species is expected as the antidote distributes into the 
circulatory system from the muscle, binding more cyanide to produce more cyanoCbi. 
This data definitively shows that cyanoCbi is produced in-vivo from the treatment of 
cyanide poisoning via administration of Cbi (i.e., without addition of excess cyanide for 
analysis) and, to our knowledge, is the first study to do so. Therefore, the hypothesized 
mechanism of treatment of Cbi for cyanide poisoning, direct binding of cyanide, was 
verified for the first time by this study.    
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In conjunction with the cyanoCbi method, the total Cbi [6] at 7.5, 10, and 15 min 
post-treatment was evaluated (Figure 2.5, inset). The difference between cyanoCbi and 
the total Cbi was considered ‘available’ Cbi. As evident by the inset, the total Cbi 
concentration increased progressively from 7.5 to 15 min, while the cyanoCbi increased 
from 7.5 to 10 min and then decreased slightly from 10 to 15 min post-treatment. The 
available Cbi increased generally linearly from 7.5 to 15 min. In terms of the percentage 
of Cbi available, the percentage of cyanoCbi, with respect to the total Cbi, was 
approximately 65%, 65%, and 50% at 7.5, 10, and 15 min, respectively. Therefore, the 
‘available’ Cbi was 35%, 35%, and 50%. The increasing ‘available’ Cbi from 7.5 to 15 
min is due to increased availability of the Cbi in the circulatory system as it distributes 
from the muscle following IM injection. The relatively stable percentage of cyanoCbi 
versus the total Cbi is likely due to the binding of CN by Cbi being governed by 
equilibrium constants. Although this study is a good first step in evaluation of the 
availability of Cbi, a more comprehensive pharmacokinetic/pharmacodynamic study 
should be performed over a longer time period than presented here (i.e., allowing the 
elimination phase to be evaluated) with analysis of cyanoCbi and total Cbi over the entire 
duration of the experiment.  
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Figure 2. 4. CyanoCbi (1015→930) chromatograms from rabbit plasma pre-CN-
exposure and pre-treatment and 10-min post-treatment from the same animal. The peak 
shape was sharp, similar to what was obtained from the method developed. 
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Figure 2. 5. CyanoCbi concentrations (circles) for a cyanide-exposed rabbit treated with 
1H-tetrazole-5-acetylcobinamide. Inset: Concentrations of total, cyano and ‘available’ 
Cbi concentrations at 7.5, 10 and 15 min following the administration of antidote. The 
‘available’ Cbi was calculated as total Cbi minus the cyanoCbi.  
 
1.12. 2.5. Conclusion 
 An LC-MS-MS method for the detection of available cyanoCbi was developed. 
The method was applied for the detection of available cyanoCbi species in plasma and 
definitively show that cyanide is bound to Cbi in-vivo. The careful selection of a 
polymeric PLRP-S column and the cleaning protocol presented here are vital for the 
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analysis of Cbi and other compounds that have similar binding characteristics. The 
availability of this method should allow more comprehensive analysis of the behavior of 
Cbi for treatment of cyanide poisoning.  In future, the method should be applied to a 
more comprehensive pharmacokinetic study. 
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CHAPTER 3. ULTRATRACE ANALYSIS OF NITROSODIPROPYLAMINE IN 
DRINKING WATER BY ICE CONCENTRATION LINKED WITH 
EXTRACTIVE STIRRER (ICECLES) AND LOW-RESOLUTION GAS 
CHROMATOGRAPHY-MASS SPECTROMETRY 
 
3.1 Abstract 
Nitrosoamines (NAs) are potent mutagens, carcinogens, and teratogens and are 
produced in drinking water as chlorination disinfection by-products. The US EPA 
estimates a 10
-6
 cancer risk of 0.2–20 ng/L for most NAs in drinking water and 
unregulated contaminant monitoring minimum reporting levels (MRL) range from 2-7 
ng/L (ppt). Analysis of NAs at these ultratrace concentrations is extremely difficult, 
requiring sophisticated instrumentation and laborious sample preparation procedures. An 
advanced sample preparation technique, ICE Concentration Linked with Extractive 
Stirrer (ICECLES), coupled to a low-resolution gas-chromatography mass-spectrometry 
instrument was used to analyze NDPA (MRL = 7 ng/L (ppt)). ICECLES allowed ultra-
trace analysis of NDPA, producing an LOD of 0.2 ng/L, and a linear range of 2 to 50 
ng/L (using an internal standard, NDPA-d14). Both inter- and intraassay precision were 
≤13%RSD, while the method accuracy was 100±17.5%. The ICECLES method was 
applied to screen for possible NA contamination in selected drinking water sources. The 
concentration of NDPA in one drinking water source was 2.38±0.34 ng/L. While NDPA 
was detected in the two other municipalities tested (i.e., concentrations > 0.2 ng/L), it was 
not quantifiable.  
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3.2.  Introduction 
 Nitrosoamines (NAs) are potent mutagens, carcinogens and teratogens [20, 189-
191]. They are highly toxic to human bladder tissue [192] and are associated with 
drinking water, food, and soil [20]. NAs have the general structure R
1
N(–R
2
)–N=O, 
where an N-nitroso (N–N=O) functional group is typically bonded to two alkyl groups 
through the amine nitrogen [193]. Table 3.1 shows the structures of the most common 
nitrosoamines, along with some of their physical properties. As seen in Table 3.1, the 
NAs have a unique combination of being highly carcinogenic, and having relatively high 
polarity, as quantified by relatively low octanol-water partition coefficients (i.e., log Kows 
range from -0.44 to 3.13). As a result of their high polarity, most NAs are difficult to 
extract with organic solvents and non-polar solid sorbents [17], making the analysis of 
low NA concentrations very difficult. 
 Common sources of NAs or their precursors can be found in food, agro-
chemicals, tanned leather products, solvents, cutting fluids, drugs, plastics, rubber 
additives, detergents, and ground water/drinking water [194]. Drinking water is perhaps 
one of the most concerning routes for NA exposure [12]. NAs are formed during the 
water purification process as a disinfection byproduct (DBP) during chlorination and 
chloramination [13-16]. Disinfectants such as chlorine, ozone, chlorine dioxide, or 
chloramines react with naturally occurring organic matter or anthropogenic contaminants 
to produce NAs [13-19]. The presence of NAs in drinking water can also result from 
contamination by industrial and or agricultural sources [13, 20], or from anion exchange 
resins [21] (i.e., anion exchange resins used to remove anionic contaminants from 
drinking can produce higher NA levels in finished products). 
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 Because of the carcinogenic nature of NAs, many established regulatory 
agencies have limited the concentration of NAs in drinking water (Table 3.1). For 
example, the U.S. Environmental Protection Agency (US EPA) estimated a lifetime 10
−6
 
cancer risk from the consumption of drinking water containing 0.2-20 ng/L of NDMA, 
NMEA, NDEA, NDPA, and NDBA [13, 195, 196]. In March 2010, the US EPA also 
categorized NDEA, NDBA and NDPA as candidate drinking water contaminants and 
designated them for unregulated contaminant monitoring at 2 to 7 ng/L [16, 20]. The 
California EPA set the 10
-6
 cancer risk levels of NAs between 1 and 15 ng/L [197]. 
Moreover, the California Department of Health Services (CDHS) set a notification  level 
of 10 ng/L for NDEA, NDPA, and NDMA [12, 191]. 
 Because each of these concentration limits are considered ultratrace, and 
because NAs are relatively polar (Table 3.1), it is very difficult to quantify them at 
these levels. Therefore, quantification of NAs has required both highly sensitive 
analysis techniques and arduous sample preparation. Several analytical methods have 
been employed to detect NAs in water samples, including gas or liquid chromatography 
with nitrogen-phosphorous detector (NPD) [150, 190, 191, 198], thermal energy 
analyzer detector (TEA) [150, 190, 191], fluorescence detector (FD) [150, 191, 199], 
and mass spectrometry (MS) detection [12, 150, 191, 198, 200, 201]. These techniques 
combined with sample preparation techniques such as solid-phase microextraction 
(SPME), liquid–liquid (LLE) and solid-phase extraction (SPE), have produced detection 
limits approaching the low ng/L [191]. However, very large sample volumes (e.g. 500-
1000 mL), long analysis times (e.g. 200 minutes), and sophisticated/expensive 
instrumentation such as GC-MS/MS, GC-HRMS, and HPLC-MS-MS are necessary to 
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reach the desired limits of detection [12, 191]. Therefore, methods capable of ultratrace 
analysis of NAs are typically too costly and time-consuming to routinely analyze NAs 
from drinking water sources [191]. Moreover, most institutions are not equipped with the 
sophisticated instrumentation necessary to perform these methods [191]. Table 3.2 
compares methods of analysis of NDPA. One low resolution GC-MS method was 
recently developed by You using SPE was able to analyze NDPA to an LOD of 0.332 
ng/L [151], but it involved a long and arduous sample preparation method involving  
passing 500 mL of water through an SPE column, elution with a hazardous solvent, 
evaporation of the solvent to a 1 mL volume (methylene chloride).    
 A novel sample preparation technique developed in our laboratory, coined ICE 
Concentration Linked with Extractive Stirrer (ICECLES), may allow analysis of NAs at 
the desired sensitivity from small sample volumes and more widely available analytical 
instrumentation [165]. ICECLES is the combination of freeze concentration and stir bar 
sorptive extraction. This process involves progressive freezing of an aqueous solution 
containing the analyte, while rapidly stirring and pre-concentrating analytes into a 
sorptive stir bar.  After the analytes are extracted into a stir bar, they are desorbed by 
heating the stir bar or are back extracted into a solvent, and then analyzed. The main 
advantages of ICECLES are higher extraction efficiencies, the ability to extract relatively 
polar analytes from aqueous solutions, and greater recoveries for more volatile 
compounds [165]. 
 The objective of the current study was to couple ICECLES with more readily 
available low resolution GC-MS instrumentation in order to detect NDPA from drinking 
water at relevant ultratrace concentrations (5-7 ng/L) from low sample volume and 
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relatively short preparation time. Because individual NAs are not typically found in 
isolation, NDPA may be a potential probe indicator of NA contamination. Upon finding 
NDPA above an acceptable limit, a more sophisticated technique to simultaneously 
analyze multiple NAs may be performed. 
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Table 3. 1.  Structures, physical properties, toxicity, and reporting levels of selected 
nitrosoamines. 
Name Chemical Structure 
Molar mass 
(g/mol) 
log 
Kow
a
 
10
-6
 Cancer 
Risk (ng/L) 
MRL 
(ng/L) 
N-nitrosodiphenylamine  
(NDPhA)
b
 
N
NO
Ph
Ph
 
198.22 3.13 - - 
N-nitrosodibutylamine 
(NDBA) 
N
NO
 
158.24 2.63 6
c
, 3
d
 4
e
 
N-nitrosodipropylamine       
(NDPA) 
N
NO
 
130.19 1.36 5
c,d
 7
e
, 10
f
 
N-nitrosomorpholine 
(NMorph) 
N
NO
O
 
116.12 -0.44 5
c,d
 - 
N-nitrosopiperidine (NPip) 
N
NO
 
114.15 0.36 3.5
c
 - 
N-nitrosodiethylamine 
(NDEA) 
N
NO
 
102.14 0.48 0.2
c
, 1
d
  3
e
, 10
f
 
N-nitrosopyrrolidine 
(NPyr), 
N
NO
 
100.12 -0.19 20
c
, 15
d
 2
e
 
N-
nitrosomethylethylamine 
(NMEA)           N
NO
 
88.11 0.04 2
c
, 1.5
d
 5
e
 
N-nitrosodimethylamine 
(NDMA) 
N
NO
 
74.08 -0.57 0.7
c
, 3
d
 2
e
 ,10
f
 
a 
Base 10 log of octanol-water partition coefficient [16, 156, 195, 196]   
b 
Ph = phenyl group (C6H5). 
c
US EPA 10
-6
 cancer risk level [197, 202]      
d 
California EPA 10
-6
 cancer risk level [197, 202, 203] 
e 
US EPA second Unregulated Contaminant Monitoring Rule (UCMR2) minimum reporting level 
[16, 193]                 
  
f 
California Department of Health Services notification level [197, 202, 203] 
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Table 3. 2. Characteristics of some NA analytical methods (ng/L). 
Method 
Sample 
Volume 
(mL) 
Sample 
Preparation 
Analysis 
Technique 
LOD 
Range 
(ng/L) 
Estimated 
analysis 
time (min) 
Qian et al. [160] 100 SPE 
HPLC-ESI-MS-
MS 
0.01-0.7 120 
You [151] 500 SPE GC-CI-MS 
0.038-
0.332 
360 
Planas et al. [150] 1000 SPE GC-EI-HRMS 0.08-1.7 200
a
 
Krauss and Hollender 
[153] 
500 SPE 
HPLC-ESI-MS-
MS 
0.10-2.40 220 
Zhao et al. [152] 500 SPE 
HPLC-ESI-MS-
MS 
0.1-10.6 150 
Munch and Basset 
[161] 
500-1000 SPE GC-CI-MS-MS 0.20-0.66 150 
Charrios et al. [148] 500 SPE GC-CI-MS 0.70-1.30 200 
Hung et al. [159] 4.5 SPME GC-CI-MS-MS 3.2-15.2 100
a
 
Ripolles et al. [162] 500 SPE 
HPLC-CI-MS-
MS 
1.0-8.0 100 
Cheng et al. [163] 500 SPE GC-CI-MS-MS 0.78-1.78 156 
 500 CSPE GC-CI-MS-MS 0.33-1.36 126 
 100 MLLE GC-CI-MS-MS 1.80-3.90 94 
Grebel et al. [158] 40 SPME GC-NPD 1-890 75 
 40 SPME GC-CI-MS 30-138 75 
  40 SPME GC-NCD 57-193 75 
Wang et al. [164] 0.1 LLE GC-EI-MS 32-100.6 90 
Current method                                  10 ICECLES GC-EI-MS 0.2 200
a
 
a
Methods with utilizing automated sample preparation 
LOD = limit of detection; SPE = solid-phase extraction; SPME = solid-phase microextraction; 
CSPE = cartridge solid-phase extraction; MLLE = microliquid liquid extraction; ICECLES = ice 
concentration linked with extractive stirrer; HPLC = high-performance liquid chromatography; 
MS = mass spectrometry; ESI = electrospray ionization; GC = gas chromatography; CI = 
chemical ionization; HR = high resolution; NPD = nitrogen phosphorous detector; NCD = 
nitrogen chemiluminesence detector; EI = electron ionization. 
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3.3. Material and methods 
3.3.1. Materials 
 All reagents were HPLC grade, unless otherwise stated. N-nitrosodipropylamine, 
(NDPA) standard (100 mg neat) was purchased from Sigma–Aldrich (St. Louis, MO, 
USA). Isotopic labelled N-nitrosodipropylamine (NDPA-d14, 98%) was obtained from 
Cambridge Isotope Laboratories, Inc, (Tewksbury, MA, USA). Isopropanol, (99.5%) was 
purchased from Fisher Scientific (Fair Lawn, NJ, USA). Water was purified using a water 
PRO PS polisher (Labconco, Kansas City, KS, USA) at a resistivity of 18.2 MΩ cm. 
Most water samples were irradiated for at least 26 hours with UV light from a xenon arc 
lamp (intensity 350 mW/cm
2
; Newport light source model 66903) to photodegrade 
inherent NDPA. All stock solutions were prepared in de-ionized irradiated water, while 
standards and blanks were prepared in irradiated tap water. A stock solution of both 
NDPA and NDPA-d14 were prepared as a 1 mM aqueous solution, placed in an amber 
bottles and stored at 4ºC, and freezer (-30 °C) respectively, to prevent decomposition of 
NDPA and NDPA-d14. Every three weeks, a new working stock solution of NDPA was 
prepared, while the working stock solution of NDPA-d14 was thawed immediately prior to 
each analysis. 
3.3.2. ICECLES Sample Preparation 
 The apparatus and the general procedure used for ICECLES were reported by 
Maslamani et al. [165]. Briefly, the apparatus consisted of five main parts: 1) a 
circulating chiller, 2) a double-walled or “jacketed” beaker, 3) magnetic stir plate 
(4.25 in × 4.25 in), 4) a sorptive stir bar, and 5) an amber glass sample vial (40 mL). The 
ICECLES sample preparation procedure consisted of adding a water sample (10 mL, 
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spiked or unspiked water with 200 µL of 1 µg/L of NDPA-d14 internal standard) to a 40 
mL glass amber vial along with a PDMS-coated stir bar. The vial was capped and placed 
into a double-walled beaker with coolant (-7 ºC) continually circulated. Isopropanol (1 
mL) was added to the bottom of the beaker to ensure adequate thermal contact between 
the vial and the cooled beaker. The stir bar was stirred at 1200 rpm, and the sample was 
allowed to freeze progressively from the bottom until the water was completely frozen. 
As the sample froze, the sorptive stir bar remained stirring on the top of the ice. After 
extraction, the PDMS stir bar containing the extracted analyte was removed from the vial 
using a clean teflon-coated magnet. 
3.3.3. Gas Chromatography-Mass Spectrometry  
All prepared stir bars were analyzed using an Agilent Technologies 7890A gas 
chromatograph and a 5975C inert XL electron ionization (EI)/chemical ionization (CI) 
mass selective detector (MSD) with Triple-Axis Detector and a Gerstel Multipurpose 
Sampler (MPS). The stir bars were thermally desorbed in a thermal desorption unit 
(TDU) in splitless mode, with NDPA trapped in a cooled injection system (CIS). The 
initial thermal desorption temperature was 60 °C (held for 0.20 min), increased linearly at 
720 °C/min to 250 °C, and then held constant at that temperature for 1.5 min. The analyte 
was collected in the CIS at -100 °C, cooled with cryogenic nitrogen. The CIS was then 
heated to 250 °C at a rate of 12 °C/s. Subsequently, NDPA was transferred to the GC 
column with initial oven temperature of 35 °C. The GC oven temperature was linearly 
increased at rate of 20 °C/min until it reached a final temperature of 240 °C. Separation 
was achieved by using an HP-5MS capillary column (30 m × 250 μm x 0.25 μm) with 
helium carrier gas at a flow rate of 1 mL/min and a column head pressure of 6.5 psi. The 
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MS source and quadrupole temperatures were 280 °C and 150 °C, respectively. Electron 
ionization was used to fragment the NDPA with a voltage of 70 eV. Acquisition was 
carried out using selected ion monitoring (SIM) for ions 70 m/z (identification, [M-
CH3CH2CH2O]
+
), and 130 m/z (quantification, [M-H]
+
) for NDPA and 144 m/z for 
NDPA-d14. The quantification ion was selected based on its signal to noise ratio. After 
confirmation of the identity of NDPA and NDPA-d14, only 130 and 144 ions respectively, 
were used in the final method with a dwell time of 500 ms. Because the analysis of 
NDPA was completed at ultratrace levels, the stir bars were conditioned and cleaned with 
the TDU conditioner system at 300 ᵒC for 3 hours, then cooled, and the absence of a 
NDPA peak in the nonspiked stir bars prior to analysis verified with the method. 
3.3.4. Method Validation  
 For the determination of the limit of detection (LOD), multiple concentrations of 
NDPA below the LLOQ were spiked in irradiated drinking water in triplicate and 
analyzed by the analytical method. The LOD was determined as the concentration that 
reproducibly generated a signal to noise ratio of 3 based on the chromatograms. Noise 
was calculated as peak-to-peak noise in the blank (i.e., non-spiked irradiated water only) 
over the retention time of NDPA. The linearity of the method was determined by 
analyzing NDPA calibration standards in irradiated drinking water with the internal 
standard (200 µL of 1 µg/L NDPA-d14) in triplicate at ten different concentrations 
ranging from 0.2 to 200 ng/L (i.e., 0.2, 0.5, 1, 2, 5, 10, 20, 50, 100, 200 ng/L). The 
average signal ratios were plotted against the corresponding nominal concentrations. The 
lower limit of quantification (LLOQ) and the upper limit of quantification (ULOQ) were 
selected based on the following inclusion criteria: precision (expressed as the relative 
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standard deviation) of <20% and an accuracy of 100±20% as calculated by comparing the 
experimental concentration to the nominal concentration of the calibrator. The analyte 
concentration was back-calculated from the calibration equation using the average signal 
ratio of each calibrator. Inter-and intraassay precision and accuracy were determined by 
analyzing low, medium, and high quality control (QC) standards in quintuplicate with 
concentrations not included in the calibration curve (i.e., 3.5, 15 and 35 ng/L, 
respectively) over three separate days and within ten calendar days. 
The stability of NDPA was determined by storing the QC samples (low and high) 
at different temperatures. The internal standard was spiked immediately prior to sample 
preparation and analysis. In order to correct for run-to-run variability, bench top and 
autosampler stability were evaluated at room temperature (RT), while the long-term 
stability was determined at 4 °C,−30 °C and −80 °C, all at multiple storage 
times/durations. The samples stored at −30 °C, and −80 °C were left to thaw unassisted at 
room temperature for analysis. For freeze-thaw stability, three set of QC standards were 
stored at -80 °C. All standards were thawed, one set was analyzed, and the rest of the QC 
standards were re-frozen at -80 °C. The process was repeated for the remainder of the 
freeze-thaw QC samples. Stability of the NDPA at a particular concentration, at any 
given storage time and temperature, was calculated as percentage of the initial signal (QC 
standards freshly prepared each day of the analysis). The NDPA was considered stable if 
the signal from the stored sample was within 10% of the freshly prepared QC standard. 
 Recovery was determined by analyzing QC standards in tap drinking water 
(irradiated), and compared to QC standards of same concentrations in de-ionized water 
(irradiated), all in quintuplicate.  The recovery was evaluated by dividing the average 
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signal of NDPA in irradiated tap water to that in irradiated de-ionized water, and 
expressed as a percentage. 
3.3.5. Sample Collection Protocol and Analysis of Water samples  
Various water samples from different locations, each with different water 
treatment facilities, were analyzed to determine NDPA contaminants. Tap water samples 
were collected from Brookings (South Dakota), Sioux Falls (South Dakota), and Lake 
Hendricks (Minnesota). The samples were collected in pre-cleaned amber vials with 
Teflon-lined polyethylene caps to prevent photodecomposition of NAs, if present. The 
cleaning protocol for the sample collection container glass vials was similar to that 
described by Maslamani et. al., [165]. The amber vials were soaked in water, methanol 
and soap for 24 h each, rinsed several times with an NDPA free-deionized (DI) water 
(i.e., irradiated DI water that was previously analyzed with the method to confirm the 
absence of NDPA), and  dried at room temperature [156] for at least 24 h. The vial was 
filled with NDPA-free DI water and stored in the refrigerator for 24 h. ICECLES analysis 
was performed (in triplicate) to ensure sampling vial cleanliness prior to sampling of the 
tap water at the various locations. Samples were collected as follows: 1) the valve of the 
water source was fully opened, and allowed to flow at full strength for about 3-5 minutes, 
2) the flow was regulated to approximately 50 mL/min, and water was collected into the 
requisite container until overflowing, then the vial was capped immediately. The water 
was stored for about 5 minutes and dumped. The  vial was then re-filled in the same 
manner and capped [165]. Samples were added to insulated containers during 
transportation. The samples were subsequently stored in the dark in the refrigerator 
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(between the temperatures of 4− 6°C) until analysis. Samples collected and stored in the 
refrigerator were analyzed within 3 days [147, 149, 204-206].  
3.4. Results and Discussion  
3.4.1 ICECLES Sample Preparation and GC-MS Analysis  
NAs, including NDPA, have relatively low log Kows, ranging from -0.57 to 3.13. 
Consequently, they are difficult to extract with organic solvents or common solid 
sorbents [16, 17]. Moreover, their Henry’s constants are very small, making it difficult to 
isolate them from the sample headspace [16]. Therefore, most methods for ultratrace NA 
analysis require very large sample volumes, arduous sample preparation, and 
sophisticated instrumentation (as seen in Table 3.2). The recently introduced ICECLES 
technique, first reported by Maslamani et al. [165], has demonstrated phenomenal 
extraction efficiencies of compounds with relatively low log Kow (<3.0). It is simpler, 
greener, and generally requires only a low resolution GC-MS for ultratrace analysis. In 
addition, the automated ICECLES procedure is a stark contrast to most SPE, MLLE, and 
LLE methods listed in Table 3.2, which require constant attention.  
For the method presented here, a PDMS-coated stir bar was added to 10 mL of tap 
water and stirred as the sample was frozen. By following the experimental procedure 
described in the method section, the stir bar remained spinning on top of the frozen 
portion of the sample. After the sample was completely frozen, the stir bar was simply 
removed from the top of the sample. NDPA was then desorbed from the stir bar via 
thermal desorption and analyzed by a low-resolution GC-MS in electron ionization mode. 
Figure 3.1A shows the selected ion chromatograms of the quantification ion for the 
analyte and internal standard, both eluting at 5.1 min. The total GC-MS run time, 
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including desorption and equilibration, was approximately 15 minutes. The NDPA peak 
was sharp but did show some minor tailing (As=1.6). The method showed excellent 
selectivity with no interferent peaks in the boiled, irradiated tap water blank. Figure 3.1B 
shows the effect of UV irradiation on the tap water, where tap water was analyzed with 
the method before and after UV irradiation. The NDPA peak disappeared after the 
irradiation with UV light. Since NDPA elutes at 5.1 min (Figure 3.1A) and it is removed 
by UV irradiation, the peak in the non-irradiated tap water can likely be attributed to 
NDPA contamination of the tap water source.  
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Figure 3. 1. Chromatograms of spiked and unspiked NDPA in irradiated tap water. A) 
Chromatograms showing the elution time of NDPA (130 m/z) and internal standard 
(NDPA-d14, 144 m/z) at 5.1 minutes. B) The effect of irradiating the tap water with 
strong UV light led to photodecomposition of NDPA from the tap water. The 
disappearance of the peak at 5.1 minutes after UV irradiation indicates a preliminary 
confirmation of the presence of NDPA in the tap water (B). 
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3.4.2. Limit of detection (LOD), signal enhancement, dynamic range, and sensitivity   
The LOD, as measured by a signal-to-noise ratio of 3, was 0.2 ng/L (i.e., 200 
ppq). The excellent LOD was due to the efficient extraction of NDPA into the PDMS stir 
bar during ICECLES. This LOD was produced via analysis with a low resolution GC-
MS, only 10 mL of sample, and automated sample preparation, in contrast to methods 
using more sophisticated instrumentation (i.e., GC-MS-MS or LC-MS-MS), larger 
sample volumes (250-1000 mL), longer sample preparation times, and sample 
preparation requiring constant attention (Table 3.2). The only method we found which 
utilizes a low resolution GC-MS,  You [151] in Table 3.2, did produce an LOD similar to 
ICECLES (0.332 ng/L), but required  500 mL of sample, about 6 hours of sample 
preparation, and constant attention during addition of the sample to the SPE cartridge 
during sample preparation.  
Theoretically, the fraction of analyte extracted (fextr) via ICECLES is governed by 
Equation 3.1, assuming complete freezing of the sample  [207]. Kice represents the 
equilibrium constant between the liquid and solid sample matrix. The Vice and VSB are the 
final volumes of the ice and the PDMS, respectively. Using the volumes in this study, a 
typical Kice of 10
-3
, and estimating KSB ≈ Kow of NDPA (i.e.,Kow is a good estimate of 
KSB, the distribution constant of the analyte between an aqueous phase and the stir bar), 
the amount of NDPA expected to be extracted into the PDMS is 99.9%. Because of their 
similarities, the performance of ICECLES relative to SBSE was also evaluated. The 
combined FC and SBSE extraction of analytes via ICECLES made it possible to 
efficiently extract NDPA (log Kow = 1.36) from drinking water, producing a signal 
enhancement of 198 versus room-temperature SBSE. 
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𝑓𝑒𝑥𝑡𝑟 =
𝐾𝑆𝐵𝑉𝑆𝐵
𝐾𝑖𝑐𝑒𝑉𝑖𝑐𝑒+𝐾𝑆𝐵𝑉𝑆𝐵
 (3.1) 
The linear range for the current method was 2 to 50 ng/L using a weighted 1/x
2
 
fitting linear regression. Because the MRL of NDPA is within the linear range, this 
method is well-suited for the evaluation of NDPA contamination in drinking water. The 
calibrator concentrations of 0.2, 0.5, 1, 100 and 200 ng/L were evaluated but did not fit 
the accuracy and precision criteria. The regression equations, correlation coefficients 
(R
2
), and the Percent Residual Accuracies (PRAs) [188] for the 3-day validation study are 
outlined in Table 3.3. The PRA values for all the calibration curves generated for the 3-
day validation process was ≥90% (Table 3.3), indicating a good fit over the entire linear 
range [188]. In addition, the precision and the accuracy of calibration curves were 
acceptable (Table 3.4) [208].  
 
Table 3. 3. Regression models, R
2
 and PRA values for separate calibration curves over a 
3-day period. 
Days Equation for line R
2
 PRA 
Day 1 y = 0.0117x+0.0139 0.9887 90.77 
Day 2 y = 0.0172x+0.0346 0.9959 91.12 
Day 3 y = 0.0174x+0.0715 0.9948 90.25 
 
a
Equation in the form of y = mx + b, where x = NDPA concentration (ng/L) and y = 
signal ratio for the peak area abundance of the 130 /144 m/z ions from the GC-MS 
chromatogram.  
b
Percent Residual Accuracy [188]. 
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3.4.3. Method Validation: Inter-assay and Intra-assay Precision and Accuracy  
The intra- and interassay precision and accuracy, determined by quintuplicate 
analysis of the QC standards (i.e., low, medium, and high) over ten calendar days, are 
shown in Table 3.4. The intra- and interassay precision of the NDPA in drinking water 
was <13% RSD, while the intra- and interassay accuracy was 100±17.5%.  
 
Table 3. 4. Intra-and Interassay accuracy and precision for ICECLES analysis for NDPA 
in drinking water. 
Nominal  Intraassay  Intraassay  Interassay  Interassay  
Conc. 
(ng/L) 
Accuracy
a
 
(%) 
Precision
a
 
(%) 
Accuracy
b
 (%) Precision
b
 (%) 
3.5 100±3 <12 100±14 <12.5 
15 100±9 <8 100±5 <11 
35 100±17.5 <10 100±8 <12 
a
 QC method validation for Day 1 (N=5), 
b
 Average QCs for 3 different days of 
validation (N=15) 
 
 
3.4.4. Matrix effect and recovery 
Matrix effect analysis provides an estimation of signal attenuation or 
enhancement that may lead to loss or gain in signal of the analyte. The matrix effect was 
estimated by comparing the slope of a calibration curve produced in irradiated tap water 
to that in irradiated-deionized water (i.e., slopetap water/ slopeDI water). The slope ratio was 
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0.83, which is suggestive of a slight matrix effect, most likely be due to ion suppression 
in the irradiated tap water. The matrix effect for the internal standard corrected-
calibration curve in both tap water (irradiated) and de-ionized was 1.02, indicating that 
the IS was effective at correcting for any variations in signals of the analyte.  
The recoveries for NDPA for low, medium, and high QCs, were 93.2, 101.3, 
85.3%, respectively. These recoveries were excellent. The relatively low recovery for the 
high QC could be due to saturation effect and/or matrix/suppression effects.  
3.4.5. NDPA Stability 
Bench top stability for the NDPA was evaluated for the low (3.5 ng/L) and high 
QC (35 ng/L) in irradiated tap water at 0, 2, 4, 8, 12 and 24 hrs. Thus, the samples were 
left on the bench top for the desired time, spiked with fresh IS and analyzed by 
ICECLES-GC-MS. NDPA (without inclusion of IS for the signal ratio) was stable up to 2 
hours (105% recovered) and began to degrade after 4 hours (88% recovered). When the 
signal ratio was considered, the IS corrected for low and high QCs for the 24-h period 
(i.e., signal ratios were between 100 and 108% of the original signal ratio). It is important 
to note that the samples were reasonably protected from light (i.e., stored in an insulated 
foam container made of thick polystyrene) while standing on the benchtop and when 
placed on the GC-MS auto-sampler (i.e., all lights were turned off during the analysis 
with GC-MS).  
Similarly, the autosampler stability was tested for 0, 2, 4, 8, 12, and 24 hours. The 
noncorrected low QC signal was not stable at any time tested within 2 hours but the high 
QC was stable up to 4 hours (Figure 3.2A). When using IS to correct for loss of signal, 
the signal ratio was stable for the 24-h period (Figure 3.2B).   
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The low QC NDPA was stable at 4 °C for 15 days, while high QC was stable for 
30 days. With IS correction, all QC signal ratios were stable for at least 30 days. Stability 
at -30 and -80 °C for both low and high QCs was stable for 30 days with and without the 
IS correction following storage. 
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Figure 3. 2. Determination of auto-sampler stability, and the ability of the IS to correct 
for signal loss at room temperature. (A) NDPA signal stability plotted without IS (B) IS 
corrected plot of NDPA signal that shows the IS corrects for instability of the analyte 
over the 24-hr period at room temperature. Signal loss of the uncorrected NDPA could be 
due to thermal or photo degradation on the autosampler. 
 
3.4.6. Analysis of Drinking Water for NDPA 
Drinking water samples from various locations in South Dakota (Brookings and 
Sioux Falls) and Minnesota (Hendricks) were obtained and analyzed with the method 
presented here. The samples were collected in amber vials, stored in pre-cleaned 1-L 
amber bottles in a refrigerator, and analyzed within three days of sampling. Figure 3.3 
below shows the chromatograms of NDPA spiked tap water (positive control) and 
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unspiked tap water sampled from Brookings. The peak at 5.1 min in the drinking water 
sample elutes at the same time as the spiked NDPA. Moreover, the NDPA peak 
disappeared when the sampled water was boiled and irradiated (similar to Figure 3.1B). 
The level of NDPA of the drinking water sampled from Brookings (SD) was 2.38±0.34 
ng/L. This concentration of NDPA was below the USEPA MRL. NDPA in the water 
samples from Sioux Falls (SD) and Hendricks (MN) was above the LOD but below the 
LLOQ for the method (i.e., signals were above the LOD of 0.2 ng/L but not within the 
linear range of the calibration curve). 
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Figure 3. 3. Chromatograms showing NDPA- spiked tap water (red), and that from 
unspiked tap water (blue) sampled in South Dakota on 02/07/2018.The concentration of 
NDPA in the unspiked tap water was between 2.04 and 2.72 ng/L at a 95% confidence 
limit. 
 
3.5. Conclusion and Future Directions 
A quick, flexible, simple, green, and relatively inexpensive method for NDPA 
analysis was developed using ICECLES sample preparation coupled with low resolution 
EI-GC-MS. This method could be expanded to more NAs (Table 3.1), or simply used for 
NDPA analysis. The use of GC-CI-MS may allow more selectivity for the NAs in Table 
3.1 and should be used as a strategy for a more comprehensive method for NAs. That 
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said, because NAs are typically found together, NDPA may be able to act as a probe 
molecule for screening drinking water. Therefore, this method could potentially be used 
to screen drinking water for NDPA, with follow-on analysis via more comprehensive 
method (see Table 3.2) if NDPA concentrations in the drinking water source are 
concerning. The figures of merit were within USEPA guidelines, and the usefulness of 
the method was verified by detecting NDPA in drinking water samples.  
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CHAPTER 4. BROADER IMPACTS, CONCLUSION AND FUTURE 
DIRECTIONS  
4.1. Broader Impacts 
 Currently, there are some limitations with the available cyanide antidotes, such as 
slow onset of action, administration requiring supportive care and trained individuals, and 
limited applicability to mass casualty situations. From recent studies, Cobinamide (Cbi) 
has shown excellent potential as a cyanide antidote. In order for the FDA to approve Cbi 
as an antidote, there is a need to conduct a comprehensive pharmacokinetic studies for 
the drug (Cbi). This includes in-vivo determination of the “available” and “total” Cbi in 
biological fluids. Therefore, a bioanalytical technique to differentiate available Cbi from 
total Cbi is vital to help the translation towards FDA approval. Consequently, the LC-
MS-MS method developed in this study should provide tremendous information for the 
advancement of this Cbi as cyanide antidote. Moreover, the data obtained from this study, 
definitely verified in-vivo the hypothesized mechanism of treatment of Cbi for cyanide 
poisoning (via direct binding of cyanide). 
Since nitrosomaines (NAs) are produced as disinfection byproducts, and are 
probable cause of cancer, it is very important to test treated water prior to delivery to 
consumers. Current methods available for NA analysis require sophisticated and 
expensive instrumentation and arduous sample preparation, some requiring hazardous 
organic. This makes monitoring of these probable carcinogenic compounds at trace levels 
in drinking water quite difficult and expensive, which limits many municipalities from 
monitoring drinking water.  Therefore, a relatively inexpensive method that utilizes a low 
resolution and inexpensive gas chromatographic instrumentation coupled with flexible, 
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automated, and greener sample preparation technique should enable monitoring of NAs at 
trace levels (i.e., MRLs) as stipulated by the USEPA. This would allow increased 
monitoring and potentially help prevent development of cancer based on NA exposure 
through drinking water consumption. The analytical method, ICECLES-GC-EI-MS, 
reported here affords a solution to the challenges associated with the current method for 
analysis of NAs at trace levels.  
Overall, the methods presented in this dissertation should help facilitate 
development of Cbi as a countermeasure for cyanide (which has ubiquitous sources) and 
facile and prompt screening of NAs in drinking water to help decrease exposure to NAS.  
4.2. Conclusions 
 The methods presented in this dissertation have significant impacts for the 
approval of Cbi as cyanide antidote, and regulation of NAs in trace amounts. We have 
shown systematically how to deal with a much known problem of residual Cbi by 
developing a comprehensive how a cleaning protocol. For the first time, we have 
developed a method that can be utilized to help in the classification and regulation of 
nitrosoamines. 
The LC-MS-MS method developed was able to analyze available Cbi, and was 
used to verify in vivo for the first time, the hypothesized mechanism of Cbi as cyanide-
binding agent, making it possible for more detailed pharmacokinetic studies of Cbi to be 
conducted, and ultimate approval by the FDA as cyanide therapeutic. 
The ICECLES sample preparation coupled with low resolution GC-EI-MS 
method reported here allows for trace analysis of NDPA, as required by the USEPA.  
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This method eliminates some of the challenges of current methods for NAs analysis, and 
helps reduce the risk of cancer associated with NAs in drinking water.  
4.3. Future Work 
Ideal cyanide antidotes are very critical in reversing cyanide poisoning in a timely 
fashion. Consequently, the use of the presented method to evaluate CyanoCbi, total Cbi, 
and available Cbi for comprehensive PK studies that facilitate the determination of a 
detailed pharmacokinetic behavior of Cbi, which will help facilitate the approval of Cbi 
as cyanide antidote. The future work will address this aspect of the research. 
The ICECLES-GC-EI-MS method should be extended to analyze more NAs in 
the future. Specifically, ICECLES sample preparation coupled with low resolution GC-
CI-MS may produce very sensitive and selective method for analysis of NAs [209]. The 
ultratrace analysis of other NAs with ICECLES-GC-CI-MS would be explored.  
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